(460491, 'HP:0012657', 'Abnormal brain positron emission tomography', 'XPO:0100587', 'abnormal vestibuloauditory system', 0.4642857142857143, 3.94131651835137, 1.3527368387638634, 'UPHENO:0004523', 'abnormal nervous system'),
(460492, 'HP:0012657', 'Abnormal brain positron emission tomography', 'XPO:0101239', 'abnormal olfactory epithelial support cell', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(460493, 'HP:0012657', 'Abnormal brain positron emission tomography', 'XPO:0100754', 'abnormal electrically active cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460494, 'HP:0012657', 'Abnormal brain positron emission tomography', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460495, 'HP:0012657', 'Abnormal brain positron emission tomography', 'XPO:0101501', 'abnormal parabrachial area', 0.43333333333333335, 3.94131651835137, 1.3068679445984308, 'UPHENO:0004523', 'abnormal nervous system'),
(460496, 'HP:0012657', 'Abnormal brain positron emission tomography', 'XPO:0100031', 'abnormal central nervous system', 0.48148148148148145, 3.94131651835137, 1.3775597686645948, 'UPHENO:0004523', 'abnormal nervous system'),
(460497, 'HP:0012657', 'Abnormal brain positron emission tomography', 'XPO:0100653', 'abnormal myoblast', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460498, 'HP:0012657', 'Abnormal brain positron emission tomography', 'XPO:0100802', 'abnormal exocrine cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460499, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0101949', 'abnormal respiratory system morphology', 0.5454545454545454, 7.241224942262181, 1.987400075328502, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460500, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0100116', 'abnormal aortic arch 1', 0.4126984126984127, 7.241224942262181, 1.7287110920173323, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460501, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0101210', 'abnormal aortic arch 2', 0.4126984126984127, 7.241224942262181, 1.7287110920173323, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460502, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0141593', 'edematous lung', 0.42857142857142855, 9.627087342903641, 2.0312298184917754, 'HP:0002088', 'Abnormal lung morphology'),
(460503, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0139850', 'abnormally necrotic respiratory system', 0.4897959183673469, 7.241224942262181, 1.8832743880539138, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460504, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0140110', 'abnormally necrotic pharynx', 0.40625, 7.241224942262181, 1.7151523643087838, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460505, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0130015', 'increased size of the respiratory system', 0.47058823529411764, 7.241224942262181, 1.8459781328463531, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460506, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0127859', 'abnormally localised larynx', 0.4067796610169492, 7.241224942262181, 1.7162700916117157, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460507, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0100262', 'abnormal aortic arch 4', 0.4126984126984127, 7.241224942262181, 1.7287110920173323, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460508, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0126855', 'abnormally localised pharynx', 0.4406779661016949, 7.241224942262181, 1.7863505478043666, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460509, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0102528', 'abnormal bronchus morphology', 0.4126984126984127, 10.802658907487096, 2.111454518582461, 'HP:0005607', 'Abnormal tracheobronchial morphology'),
(460510, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0101036', 'abnormal pharynx', 0.5098039215686274, 7.241224942262181, 1.9213549574521147, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460511, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0101474', 'abnormal aortic arch 5', 0.4126984126984127, 7.241224942262181, 1.7287110920173323, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460512, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0127240', 'abnormally localised pharyngeal epithelium', 0.40625, 7.241224942262181, 1.7151523643087838, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460513, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0100875', 'abnormal oropharynx', 0.48148148148148145, 7.241224942262181, 1.8672213883043034, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460514, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0100716', 'abnormal aortic arch 3', 0.4126984126984127, 7.241224942262181, 1.7287110920173323, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460515, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0128535', 'decreased size of the respiratory system', 0.47058823529411764, 7.241224942262181, 1.8459781328463531, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460516, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0102436', 'abnormal larynx morphology', 0.42105263157894735, 7.241224942262181, 1.746120504946495, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460517, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0126955', 'abnormally localised oropharynx', 0.41935483870967744, 7.241224942262181, 1.7425965447351404, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460518, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0100586', 'abnormal thyroid primordium', 0.4727272727272727, 7.241224942262181, 1.8501687809927785, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460519, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0125599', 'absent pharyngeal epithelium', 0.40625, 7.241224942262181, 1.7151523643087838, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460520, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0101329', 'abnormal pharyngeal epithelium', 0.5, 7.241224942262181, 1.9027907060764961, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460521, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0100804', 'abnormal larynx', 0.4897959183673469, 7.241224942262181, 1.8832743880539138, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460522, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0141648', 'neoplastic lung', 0.42857142857142855, 9.627087342903641, 2.0312298184917754, 'UPHENO:0019970', 'abnormal lung morphology'),
(460523, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0141614', 'metaplastic larynx', 0.46153846153846156, 7.241224942262181, 1.8281421770490451, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460524, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0101548', 'abnormal pulmonary vein', 0.4576271186440678, 9.627087342903641, 2.0989559885018476, 'HP:0002088', 'Abnormal lung morphology'),
(460525, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0102932', 'abnormal lung morphology', 0.45, 9.627087342903641, 2.0813911944434276, 'UPHENO:0019970', 'abnormal lung morphology'),
(460526, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0102668', 'abnormal pharynx morphology', 0.4406779661016949, 7.241224942262181, 1.7863505478043666, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460527, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0125326', 'absent oropharynx', 0.40625, 7.241224942262181, 1.7151523643087838, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460528, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0125232', 'absent pharynx', 0.43333333333333335, 7.241224942262181, 1.7714017448469856, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460529, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0100117', 'abnormal aortic arch', 0.41935483870967744, 7.241224942262181, 1.7425965447351404, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460530, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0100210', 'abnormal pulmonary artery', 0.4576271186440678, 9.627087342903641, 2.0989559885018476, 'HP:0002088', 'Abnormal lung morphology'),
(460531, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0100360', 'abnormal aortic arch 6', 0.4126984126984127, 7.241224942262181, 1.7287110920173323, 'HP:0012252', 'Abnormal respiratory system morphology'),
(460532, 'HP:0100552', 'Neoplasm of the tracheobronchial system', 'XPO:0102974', 'abnormal trachea morphology', 0.40625, 10.802658907487096, 2.0948938352973006, 'HP:0005607', 'Abnormal tracheobronchial morphology'),
(460533, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100985', 'abnormal simple columnar epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460534, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101497', 'abnormal ciliary axoneme', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460535, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100989', 'abnormal right blastomere', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460536, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100308', 'abnormal early embryonic cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460537, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131691', 'abnormal molecular function', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460538, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100862', 'abnormal blastomere V1', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460539, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100503', 'abnormal blastomere D2', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460540, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141715', 'abnormal septum', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460541, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100999', 'abnormal serous membrane', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460542, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141748', 'abnormal gas homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460543, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107267', 'abnormal ventral side', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460544, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100108', 'abnormal cell part', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460545, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101311', 'abnormal bottle cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460546, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100255', 'abnormal pelvic appendage', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460547, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100398', 'abnormal vegetal blastomere', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460548, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101263', 'abnormal blastocoel floor', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460549, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100444', 'abnormal cement gland', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460550, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101406', 'abnormal cleavage furrow', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460551, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100642', 'abnormal gustatory system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460552, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100249', 'abnormal avascular GAG-rich matrix', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460553, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100581', 'abnormal immune system', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460554, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100277', 'abnormal blastocoel', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460555, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100627', 'abnormal pharyngeal region', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460556, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101010', 'abnormal dorsal marginal zone', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460557, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460558, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141782', 'abnormal methylation', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460559, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101283', 'abnormal left-ventral blastomere', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460560, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107284', 'abnormal migrating myoblast', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460561, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100251', 'abnormal proteinaceous extracellular matrix', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460562, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115758', 'abnormally decreased mobility of melanoblast', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460563, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100605', 'abnormal prechordal plate', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460564, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100523', 'abnormal midgut', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460565, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141797', 'abnormal hydrogen metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460566, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460567, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101264', 'abnormal mitotic spindle', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460568, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141267', 'abnormal resting posture', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460569, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101573', 'abnormal peripheral vegetal yolk mass', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460570, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100146', 'abnormal primary germ layer', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460571, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100481', 'abnormal anatomical line', 0.5625, 1.706362323152461, 0.9797085315405084, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460572, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100762', 'abnormal intersomitic region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460573, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100172', 'abnormal stem cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460574, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101136', 'abnormal ooplasm', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460575, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100823', 'abnormal blood', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460576, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131469', 'abnormal heart process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460577, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141784', 'abnormal cellular hormone metabolic process', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460578, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101543', 'abnormal external gill', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460579, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101976', 'abnormal portion of organism substance morphology', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460580, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107261', 'abnormal dorsal-ventral axis', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460581, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100093', 'abnormal simple squamous epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460582, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100547', 'abnormal blastomere V2', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460583, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141777', 'abnormal catabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460584, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107253', 'abnormal enteric nervous system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460585, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100664', 'abnormal periocular region', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460586, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100745', 'abnormal anterior lymph sac', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460587, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141265', 'abnormal escape behavior', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460588, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100067', 'abnormal animal hemisphere', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460589, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100599', 'abnormal adult immune system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460590, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101368', 'abnormal regenerating eye', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460591, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460592, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100867', 'abnormal apical mesenchyme', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460593, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460594, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100307', 'abnormal blastomere', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460595, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100784', 'abnormal left blastomere', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460596, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101092', 'abnormal dorso-lateral marginal zone', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460597, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460598, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100433', 'abnormal pectoral appendage', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460599, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107285', 'abnormal flexural organ', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460600, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100100', 'abnormal muscle', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460601, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100722', 'abnormal barbel', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460602, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101061', 'abnormal plasma membrane', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460603, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100872', 'abnormal neuroendocrine cell', 0.52, 6.2194654996189955, 1.7983664976310803, 'UPHENO:0003116', 'abnormal endocrine system'),
(460604, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107276', 'abnormal dorsal region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460605, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101740', 'abnormal cell part morphology', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460606, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100482', 'abnormal Mullerian duct', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460607, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100724', 'abnormal kinetochore', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460608, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141795', 'abnormal glycosylation', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(460609, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100638', 'abnormal polar body', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460610, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101083', 'abnormal T cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460611, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100189', 'abnormal enteroendocrine cell', 0.52, 6.2194654996189955, 1.7983664976310803, 'UPHENO:0003116', 'abnormal endocrine system'),
(460612, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101109', 'abnormal egg cell-free extract', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460613, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100799', 'abnormal genital ridge', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460614, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100295', 'abnormal extracellular matrix', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460615, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100976', 'abnormal multiciliated cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460616, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101518', 'abnormal B cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460617, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100846', 'abnormal hindlimb', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460618, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460619, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100760', 'abnormal Stirnorgan', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460620, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100285', 'abnormal progenitor cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460621, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101533', 'abnormal simple cuboidal epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460622, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460623, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107272', 'abnormal axial region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460624, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100545', 'abnormal male organism', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460625, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107312', 'abnormal filopodium', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460626, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0126321', 'abnormally localised anatomical structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460627, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100701', 'abnormal microglial cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460628, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101224', 'abnormal dorsal involuting marginal zone', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460629, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131730', 'abnormal regulation of protein folding', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460630, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100917', 'abnormal stage III oocyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460631, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101326', 'abnormal cementoblast', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460632, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100816', 'abnormal blastocoel anlage', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460633, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101450', 'abnormal myeloid cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460634, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460635, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141600', 'absent metamorphosis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460636, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100003', 'abnormal organism subdivision', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460637, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101212', 'abnormal glomeral mesenchyme', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460638, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101403', 'abnormal basal lamina', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460639, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100274', 'abnormal sensory system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460640, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101472', 'abnormal zygote cortex', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460641, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101396', 'abnormal apical epithelial cap', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460642, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101074', 'abnormal germinal vesicle', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460643, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100549', 'abnormal mitotic cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460644, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115566', 'abnormal variability of size of forelimb', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460645, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101402', 'abnormal oropharyngeal papilla', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460646, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141770', 'abnormal urate homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460647, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141266', 'abnormal surface breathing', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460648, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107258', 'abnormal anatomical axis', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460649, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141628', 'metaplastic thymus', 0.40625, 6.2194654996189955, 1.5895464319170476, 'UPHENO:0003116', 'abnormal endocrine system'),
(460650, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101377', 'abnormal manicotto glandulare', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460651, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100339', 'abnormal circumblastoporal collar', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460652, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100501', 'abnormal urogenital system', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460653, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100392', 'abnormal cilium', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460654, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107260', 'abnormal anterior-posterior axis', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460655, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100894', 'abnormal nucleus', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460656, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100900', 'abnormal angioblast', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460657, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141718', 'abnormal posterior notochord', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460658, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100273', 'abnormal visual system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460659, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0133403', 'abnormal developmental process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460660, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100991', 'abnormal iliac process primordium', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460661, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100231', 'abnormal compound organ', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460662, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100756', 'abnormal adrenal medulla', 0.43333333333333335, 6.2194654996189955, 1.6416764956901726, 'UPHENO:0003116', 'abnormal endocrine system'),
(460663, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0116494', 'absent biological process', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460664, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100509', 'abnormal germ plasm', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460665, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100258', 'abnormal organ part', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460666, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141798', 'abnormal lipid metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(460667, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141860', 'abnormal malate-aspartate shuttle', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(460668, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131729', 'abnormal regulation of growth rate', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460669, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101174', 'abnormal articular system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460670, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101057', 'abnormal vegetal pole', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460671, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100640', 'abnormal notochordal sheath', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460672, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460673, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101099', 'abnormal ventro-lateral marginal zone', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460674, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141786', 'abnormal pigment metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460675, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100477', 'abnormal pericyte', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460676, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100807', 'abnormal matrix-based tissue', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460677, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100856', 'abnormal simple organ', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460678, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101468', 'abnormal stage I oocyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460679, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100887', 'abnormal right-dorsal blastomere', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460680, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101302', 'abnormal subcortical cytoplasm', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460681, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101023', 'abnormal ultimobranchial body', 0.5652173913043478, 6.2194654996189955, 1.874926682567092, 'UPHENO:0003116', 'abnormal endocrine system'),
(460682, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100521', 'abnormal animal blastomere', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460683, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101096', 'abnormal tendon', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460684, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115362', 'abnormally decreased adhesivity of prechordal plate', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460685, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100135', 'abnormal surface structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460686, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100573', 'abnormal extraembryonic structure', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460687, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100913', 'abnormal Brachets cleft', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460688, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100715', 'abnormal ciliated cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460689, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100225', 'abnormal endocrine system', 0.65, 6.2194654996189955, 2.010634868580655, 'UPHENO:0003116', 'abnormal endocrine system'),
(460690, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101187', 'abnormal dorsolateral commissural neuron', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460691, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460692, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100612', 'abnormal unilaminar epithelium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460693, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100781', 'abnormal presumptive ectoderm', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460694, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100643', 'abnormal thoracic region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460695, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100916', 'abnormal principal cavity', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460696, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100616', 'abnormal ventral blood island', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460697, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107278', 'abnormal medial region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460698, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131669', 'abnormal Roux spot', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460699, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100721', 'abnormal centromere', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460700, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141272', 'absent surface breathing', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460701, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100728', 'abnormal cell condensation', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460702, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100156', 'abnormal foregut', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460703, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141907', 'abnormal putrescine metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(460704, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100337', 'abnormal zygote', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460705, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101107', 'abnormal erythroid cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460706, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100843', 'abnormal fasciculated network of fibrils', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460707, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141790', 'abnormal cellular metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(460708, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141771', 'abnormal urea homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460709, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100384', 'abnormal amputated tissue', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460710, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107269', 'abnormal right side', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460711, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100175', 'abnormal migrating neuroblast', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460712, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100842', 'abnormal left-dorsal blastomere', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460713, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141754', 'abnormal homeostatic process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460714, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0126814', 'abnormally localised endocrine system', 0.4482758620689655, 6.2194654996189955, 1.669741374719419, 'UPHENO:0003116', 'abnormal endocrine system'),
(460715, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101202', 'abnormal thymus', 0.4482758620689655, 6.2194654996189955, 1.669741374719419, 'UPHENO:0003116', 'abnormal endocrine system'),
(460716, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100196', 'abnormal neuron', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460717, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100974', 'abnormal cardiac mesoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460718, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141783', 'abnormal collagen metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460719, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100754', 'abnormal electrically active cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460720, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100858', 'abnormal presumptive midbrain-hindbrain boundary', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460721, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100207', 'abnormal blastema', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460722, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107273', 'abnormal basal region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460723, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100416', 'abnormal ligament', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460724, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0142054', 'abnormal digestive tract', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460725, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100800', 'abnormal ventral marginal zone', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460726, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100203', 'abnormal endocrine cell', 0.5416666666666666, 6.2194654996189955, 1.835450120713433, 'UPHENO:0003116', 'abnormal endocrine system'),
(460727, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100386', 'abnormal limb', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460728, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460729, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460730, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100427', 'abnormal olfactory system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460731, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100854', 'abnormal spiracle', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460732, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100417', 'abnormal dense regular connective tissue', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460733, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141714', 'abnormal anterior notochord', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460734, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100902', 'abnormal spermatocyte', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460735, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100187', 'abnormal regenerating limb', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460736, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0128000', 'absent behavior', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460737, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100551', 'abnormal oocyte cortex', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460738, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101113', 'abnormal stage IV oocyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460739, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460740, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100868', 'abnormal transporting epithelium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460741, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100786', 'abnormal presumptive axial mesoderm', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460742, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100152', 'abnormal alimentary system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460743, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0142051', 'abnormal cerebrospinal fluid', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460744, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460745, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100070', 'abnormal anatomical system', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460746, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460747, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141271', 'increased surface breathing', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460748, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100293', 'abnormal duct', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460749, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141629', 'metaplastic thyroid', 0.4482758620689655, 6.2194654996189955, 1.669741374719419, 'UPHENO:0003116', 'abnormal endocrine system'),
(460750, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100267', 'abnormal wound epidermis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460751, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100653', 'abnormal myoblast', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460752, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0126542', 'abnormally localised endocrine cell', 0.40625, 6.2194654996189955, 1.5895464319170476, 'UPHENO:0003116', 'abnormal endocrine system'),
(460753, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101078', 'abnormal mucous gland', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460754, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100378', 'abnormal perichondrium', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460755, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101149', 'abnormal amputated limb', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460756, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101587', 'abnormal hemangioblast', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460757, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101168', 'abnormal circulating cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460758, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141775', 'abnormal nitrogen compound metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460759, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141778', 'abnormal biosynthetic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460760, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100103', 'abnormal trunk', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460761, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101490', 'abnormal ectodermal cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460762, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101435', 'abnormal paracrine cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460763, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107265', 'abnormal posterior side', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460764, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100674', 'abnormal secondary oogonium', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460765, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0142056', 'abnormal main body axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460766, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101409', 'abnormal perivitelline space', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460767, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0126318', 'abnormally localised cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460768, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141791', 'abnormal primary metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460769, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460770, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0127101', 'abnormally localised portion of organism substance', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460771, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131675', 'abnormal spindle microtubule', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460772, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100120', 'abnormal genital system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460773, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100423', 'abnormal process', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460774, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0124719', 'absent anatomical structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460775, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100415', 'abnormal secretory epithelial cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460776, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101176', 'abnormal non-ciliated epithelial cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460777, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115391', 'abnormally undifferentiated alimentary system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460778, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100332', 'abnormal germinal granule', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460779, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100256', 'abnormal paired appendage', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460780, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100484', 'abnormal cement gland primordium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460781, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107263', 'abnormal anatomical side', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460782, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100864', 'abnormal dorsolateral ascending neuron', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460783, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100890', 'abnormal pharyngeal cavity', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460784, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100907', 'abnormal cytoplasm', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460785, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107288', 'abnormal larval alimentary system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460786, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100727', 'abnormal odontogenic papilla', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460787, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101004', 'abnormal acid secreting cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460788, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100956', 'abnormal centrosome', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460789, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460790, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101133', 'abnormal motor neuron', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460791, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101098', 'abnormal mineralized extracellular matrix', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460792, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101090', 'abnormal adrenal gland', 0.48148148148148145, 6.2194654996189955, 1.7304789691815143, 'UPHENO:0003116', 'abnormal endocrine system'),
(460793, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100742', 'abnormal musculoskeletal system', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460794, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101575', 'abnormal vitelline membrane', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460795, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100610', 'abnormal appendage', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460796, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101349', 'abnormal trunk region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460797, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100667', 'abnormal vegetal yolk mass', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460798, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100888', 'abnormal microtubule', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460799, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0102113', 'abnormal anatomical line morphology', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460800, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100004', 'abnormal cell', 0.55, 1.8210412618256888, 1.0007860380741376, 'HP:0000118', 'Phenotypic abnormality'),
(460801, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100282', 'abnormal pelvic girdle primordium', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460802, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100014', 'abnormal tissue', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460803, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100228', 'abnormal skeletal subdivision', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460804, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100458', 'abnormal autopod', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460805, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100202', 'abnormal embryo', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460806, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100059', 'abnormal regenerating tail', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460807, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100935', 'abnormal skeleton', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460808, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101366', 'abnormal morula cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460809, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101200', 'abnormal joint region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460810, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107326', 'abnormal regenerating pelvic girdle', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460811, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100585', 'abnormal elastica externa', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460812, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100553', 'abnormal laryngeal muscle primordium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460813, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100704', 'abnormal Merkel cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460814, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101269', 'abnormal mesodermal cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460815, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115473', 'abnormally delayed phase of Mullerian duct', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460816, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101378', 'abnormal blastomere D1', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460817, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101162', 'abnormal stromal cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460818, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460819, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100028', 'abnormal anatomical cluster', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460820, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100429', 'abnormal spermatid', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460821, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100289', 'abnormal chondroblast', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460822, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100587', 'abnormal vestibuloauditory system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460823, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460824, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0126624', 'abnormally localised anatomical line', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460825, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100031', 'abnormal central nervous system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460826, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100588', 'abnormal unicellular gland', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460827, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100151', 'abnormal primordium', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460828, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141787', 'abnormal hormone metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460829, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100515', 'abnormal somatic stem cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460830, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101519', 'abnormal hypobranchial placode', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460831, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100852', 'abnormal interdigital region', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460832, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100060', 'abnormal regenerating tissue', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460833, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100062', 'abnormal anatomical space', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460834, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100707', 'abnormal central vegetal yolk mass', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460835, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141794', 'abnormal prosthetic group metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460836, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107262', 'abnormal left-right axis', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460837, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100688', 'abnormal adipose tissue', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460838, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0142057', 'abnormal desmosome', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460839, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100954', 'abnormal neural progenitor cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460840, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100827', 'abnormal atypical epithelium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460841, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100702', 'abnormal glial cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460842, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100574', 'abnormal gastrula cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460843, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101132', 'abnormal apoptotic cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460844, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101589', 'abnormal blastocoel roof', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460845, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100422', 'abnormal notochord', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460846, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100437', 'abnormal proepicardium', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460847, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107311', 'abnormal apical junction complex', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460848, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100162', 'abnormal presumptive rhombomere', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460849, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100802', 'abnormal exocrine cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460850, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107271', 'abnormal apical region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460851, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141264', 'abnormal schooling behavior', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460852, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100557', 'abnormal prime meridian', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460853, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101141', 'abnormal Keller explant', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460854, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100376', 'abnormal animal pole', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460855, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100025', 'abnormal oocyte', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460856, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100403', 'abnormal forelimb', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460857, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460858, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101638', 'abnormal anatomical structure morphology', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460859, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101513', 'abnormal basal body', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460860, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100540', 'abnormal left lymph heart', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460861, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101713', 'abnormal anatomical entity in vitro morphology', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460862, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100069', 'abnormal urinary system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460863, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141276', 'decreased surface breathing', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460864, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100084', 'abnormal anatomical group', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460865, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141841', 'abnormality of whole organism mass', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460866, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101411', 'abnormal marginal zone (sensu neural)', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460867, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101040', 'abnormal axial mesoderm', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460868, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0125007', 'absent anatomical line', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460869, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100741', 'abnormal blastopore', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460870, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100546', 'abnormal whole organism', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460871, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141904', 'abnormal glucosamine metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460872, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460873, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115574', 'abnormal variability of size of hindlimb', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460874, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100393', 'abnormal involuting marginal zone', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460875, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100537', 'abnormal medium cavity', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460876, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101029', 'abnormal right spleen primordium', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460877, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107264', 'abnormal anterior side', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460878, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141892', 'abnormal inositol metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(460879, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100363', 'abnormal cardiovascular system', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460880, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107270', 'abnormal proximal-distal axis', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460881, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141745', 'abnormal creatinine homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460882, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100006', 'abnormal anatomical structure', 0.5625, 1.706362323152461, 0.9797085315405084, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460883, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100344', 'abnormal portion of organism substance', 0.5625, 1.706362323152461, 0.9797085315405084, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460884, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100188', 'abnormal delta cell', 0.41935483870967744, 6.2194654996189955, 1.6149807898093176, 'UPHENO:0003116', 'abnormal endocrine system'),
(460885, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100218', 'abnormal epithelial cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460886, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100665', 'abnormal egg jelly', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460887, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:00000000', 'Xenopus phenotype', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460888, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101362', 'abnormal vegetal cortex', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460889, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101157', 'abnormal female organism', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460890, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100026', 'abnormal germ cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460891, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101460', 'abnormal fibrocellular pad', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460892, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0116091', 'abnormally increased variability of size of cell in endoderm', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460893, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101220', 'abnormal centriole', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460894, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100493', 'abnormal liver and biliary system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460895, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100023', 'abnormal mesenchyme', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460896, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100176', 'abnormal stage VI oocyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460897, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0115505', 'dead whole organism', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460898, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100114', 'abnormal peripheral nervous system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460899, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100626', 'abnormal primordial germ cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460900, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100750', 'abnormal regenerating fin', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460901, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100394', 'abnormal marginal zone', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460902, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460903, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141772', 'abnormal water homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460904, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100192', 'abnormal epithelium', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460905, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100377', 'abnormal connective tissue', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460906, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100296', 'abnormal tail region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460907, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101463', 'abnormal right-ventral blastomere', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460908, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131687', 'abnormal astral microtubule', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460909, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.5625, 1.706362323152461, 0.9797085315405084, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460910, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100261', 'abnormal multilaminar epithelium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460911, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101221', 'abnormal larval immune system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460912, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100726', 'abnormal tail', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460913, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101503', 'abnormal organ cortex', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460914, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101461', 'abnormal sperm entry point', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460915, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100133', 'abnormal solid compound organ', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460916, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101577', 'abnormal notochordal epithelium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460917, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100186', 'abnormal uveal tract', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460918, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100533', 'abnormal melanoblast', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460919, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100372', 'abnormal hematological system', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460920, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101560', 'abnormal compound organ component', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460921, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101501', 'abnormal parabrachial area', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460922, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101347', 'abnormal hindlimb region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460923, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101297', 'abnormal barrier cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460924, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101389', 'abnormal wedge region', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460925, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100915', 'abnormal dermal system', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460926, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141743', 'abnormal chemical homeostasis within a tissue', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460927, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131745', 'abnormal axis elongation', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(460928, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460929, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100104', 'abnormal embryonic structure', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460930, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141499', 'abnormal tadpole', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460931, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100840', 'abnormal thyroid', 0.5, 6.2194654996189955, 1.763443435386998, 'UPHENO:0003116', 'abnormal endocrine system'),
(460932, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141497', 'abnormal lymphoblast', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460933, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131677', 'abnormal actin filament', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460934, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100383', 'abnormal amputated fin', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460935, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100402', 'abnormal zeugopod', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460936, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101553', 'abnormal dental epithelium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460937, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100449', 'abnormal lymphocyte', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460938, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107339', 'abnormal yolk platelet', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460939, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101467', 'abnormal alkali secreting cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460940, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100032', 'abnormal nervous system', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460941, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100002', 'abnormal head', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460942, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100735', 'abnormal hindgut', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460943, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100242', 'abnormal right lymph heart', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460944, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100511', 'abnormal stylopod', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460945, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107266', 'abnormal dorsal side', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460946, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100465', 'abnormal skeletal system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460947, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141315', 'abnormal anatomical region', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460948, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100468', 'abnormal muscular system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460949, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100687', 'abnormal periotic region', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460950, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101498', 'abnormal stage II oocyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460951, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0133388', 'absent insulin receptor signaling pathway', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460952, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100734', 'abnormal lateral line system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460953, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100009', 'abnormal multi-tissue structure', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460954, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141263', 'abnormal visually guided collision avoidance behavior', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460955, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100531', 'abnormal proliferative region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460956, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141809', 'abnormal catalytic activity', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460957, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100486', 'abnormal oral evagination', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460958, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141776', 'abnormal metabolic process', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460959, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101535', 'abnormal absorptive cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460960, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141781', 'abnormal secondary metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460961, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100268', 'abnormal circulatory system', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460962, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101451', 'abnormal dorsal lymph space', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460963, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100164', 'abnormal neural nucleus', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460964, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100265', 'abnormal sensory epithelial cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460965, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100232', 'abnormal lymphatic system', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460966, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141792', 'abnormal small molecule metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460967, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101110', 'abnormal cell-free extract', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460968, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100309', 'abnormal vegetal hemisphere', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460969, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460970, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101500', 'abnormal endodermal cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(460971, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100317', 'abnormal respiratory system', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460972, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101424', 'abnormal coelomic epithelium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460973, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100912', 'abnormal trabecula', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460974, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100796', 'abnormal pseudoblastema', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460975, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100201', 'abnormal cavitated compound organ', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460976, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0142052', 'abnormal nasal region', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(460977, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101857', 'abnormal endocrine system morphology', 0.43333333333333335, 6.2194654996189955, 1.6416764956901726, 'UPHENO:0003116', 'abnormal endocrine system'),
(460978, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101480', 'abnormal stage V oocyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(460979, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0131666', 'abnormal adherens junction', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(460980, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101570', 'abnormal forelimb region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460981, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100860', 'abnormal parathyroid', 0.52, 6.2194654996189955, 1.7983664976310803, 'UPHENO:0003116', 'abnormal endocrine system'),
(460982, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100158', 'abnormal neuromere', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(460983, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101405', 'abnormal ring structure', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460984, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0141796', 'abnormal demethylation', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(460985, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101072', 'abnormal mitochondrial cloud', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460986, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0100205', 'abnormal limb segment', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(460987, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0101237', 'abnormal mucus secreting cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(460988, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0116434', 'abnormal biological process', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(460989, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0125191', 'absent endocrine system', 0.41935483870967744, 6.2194654996189955, 1.6149807898093176, 'UPHENO:0003116', 'abnormal endocrine system'),
(460990, 'HP:0008373', 'Puberty and gonadal disorders', 'XPO:0107268', 'abnormal left side', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460991, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101601', 'abnormal proctodeum', 0.40540540540540543, 5.05060299610679, 1.4309233924911664, 'HP:0025031', 'Abnormality of the digestive system'),
(460992, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102733', 'abnormal posterior foregut morphology', 0.4090909090909091, 5.725717590856133, 1.5304701939081158, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(460993, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101788', 'abnormal foregut morphology', 0.4186046511627907, 5.725717590856133, 1.5481640787645816, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(460994, 'HP:0004791', 'Esophageal ulceration', 'XPO:0142061', 'abnormal digestive tract morphology', 0.43902439024390244, 5.725717590856133, 1.5854745895265556, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(460995, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100462', 'abnormal anterior foregut', 0.4166666666666667, 5.05060299610679, 1.45066119926208, 'HP:0025031', 'Abnormality of the digestive system'),
(460996, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101288', 'abnormal external coil of the small intestine', 0.44, 8.037124161124119, 1.8805144591027776, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(460997, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102367', 'abnormal hindgut morphology', 0.4186046511627907, 5.725717590856133, 1.5481640787645816, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(460998, 'HP:0004791', 'Esophageal ulceration', 'XPO:0107294', 'abnormal intestinal stem cell', 0.4074074074074074, 8.037124161124119, 1.809525881963287, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(460999, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102118', 'abnormal oral evagination morphology', 0.42857142857142855, 5.725717590856133, 1.5664861849086864, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461000, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102094', 'abnormal anterior foregut morphology', 0.4090909090909091, 5.725717590856133, 1.5304701939081158, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461001, 'HP:0004791', 'Esophageal ulceration', 'XPO:0133434', 'abnormal cilium morphology in the esophagus', 0.42857142857142855, 11.61213700143767, 2.23083619826138, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(461002, 'HP:0004791', 'Esophageal ulceration', 'XPO:0139906', 'abnormally necrotic alimentary system', 0.4090909090909091, 5.725717590856133, 1.5304701939081158, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461003, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102522', 'abnormal pharyngeal cavity morphology', 0.46153846153846156, 5.725717590856133, 1.6256195397716668, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461004, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100152', 'abnormal alimentary system', 0.46875, 5.05060299610679, 1.5386585568036393, 'HP:0025031', 'Abnormality of the digestive system'),
(461005, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100523', 'abnormal midgut', 0.42857142857142855, 5.05060299610679, 1.471238981671103, 'HP:0025031', 'Abnormality of the digestive system'),
(461006, 'HP:0004791', 'Esophageal ulceration', 'XPO:0107288', 'abnormal larval alimentary system', 0.45454545454545453, 5.05060299610679, 1.5151662069205463, 'HP:0025031', 'Abnormality of the digestive system'),
(461007, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100493', 'abnormal liver and biliary system', 0.45454545454545453, 5.05060299610679, 1.5151662069205463, 'HP:0025031', 'Abnormality of the digestive system'),
(461008, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100718', 'abnormal ventral pancreatic bud', 0.40540540540540543, 5.05060299610679, 1.4309233924911664, 'HP:0025031', 'Abnormality of the digestive system'),
(461009, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101321', 'abnormal duodenum', 0.44, 8.037124161124119, 1.8805144591027776, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(461010, 'HP:0004791', 'Esophageal ulceration', 'XPO:0129821', 'increased size of the pharyngeal cavity', 0.4090909090909091, 5.725717590856133, 1.5304701939081158, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461011, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100735', 'abnormal hindgut', 0.42857142857142855, 5.05060299610679, 1.471238981671103, 'HP:0025031', 'Abnormality of the digestive system'),
(461012, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100986', 'abnormal gut epithelium', 0.4166666666666667, 5.05060299610679, 1.45066119926208, 'HP:0025031', 'Abnormality of the digestive system'),
(461013, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102125', 'abnormal liver and biliary system morphology', 0.43902439024390244, 5.725717590856133, 1.5854745895265556, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461014, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100486', 'abnormal oral evagination', 0.42857142857142855, 5.05060299610679, 1.471238981671103, 'HP:0025031', 'Abnormality of the digestive system'),
(461015, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100156', 'abnormal foregut', 0.42857142857142855, 5.05060299610679, 1.471238981671103, 'HP:0025031', 'Abnormality of the digestive system'),
(461016, 'HP:0004791', 'Esophageal ulceration', 'XPO:0103013', 'abnormal ventral foregut morphology', 0.4090909090909091, 5.725717590856133, 1.5304701939081158, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461017, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102155', 'abnormal midgut morphology', 0.4186046511627907, 5.725717590856133, 1.5481640787645816, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461018, 'HP:0004791', 'Esophageal ulceration', 'XPO:0141819', 'neoplastic esophagus', 0.4444444444444444, 11.61213700143767, 2.2717723870178417, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(461019, 'HP:0004791', 'Esophageal ulceration', 'XPO:0107375', 'abnormal larval alimentary system morphology', 0.43902439024390244, 5.725717590856133, 1.5854745895265556, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461020, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101306', 'abnormal ileum', 0.44, 8.037124161124119, 1.8805144591027776, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(461021, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101101', 'abnormal posterior foregut', 0.4166666666666667, 5.05060299610679, 1.45066119926208, 'HP:0025031', 'Abnormality of the digestive system'),
(461022, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101021', 'abnormal dorsal foregut', 0.4166666666666667, 5.05060299610679, 1.45066119926208, 'HP:0025031', 'Abnormality of the digestive system'),
(461023, 'HP:0004791', 'Esophageal ulceration', 'XPO:0115392', 'abnormally incomplete structure of alimentary system', 0.45, 5.725717590856133, 1.6051706812315194, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461024, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101471', 'abnormal rectum', 0.41509433962264153, 8.037124161124119, 1.8265171080849456, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(461025, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101169', 'abnormal hepato-pancreatic duct', 0.40540540540540543, 5.05060299610679, 1.4309233924911664, 'HP:0025031', 'Abnormality of the digestive system'),
(461026, 'HP:0004791', 'Esophageal ulceration', 'XPO:0128341', 'decreased size of the pharyngeal cavity', 0.4090909090909091, 5.725717590856133, 1.5304701939081158, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461027, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102618', 'abnormal gut epithelium morphology', 0.4090909090909091, 5.725717590856133, 1.5304701939081158, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461028, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100361', 'abnormal small intestine', 0.4489795918367347, 8.037124161124119, 1.899606465929895, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(461029, 'HP:0004791', 'Esophageal ulceration', 'XPO:0115391', 'abnormally undifferentiated alimentary system', 0.45454545454545453, 5.05060299610679, 1.5151662069205463, 'HP:0025031', 'Abnormality of the digestive system'),
(461030, 'HP:0004791', 'Esophageal ulceration', 'XPO:0100890', 'abnormal pharyngeal cavity', 0.4411764705882353, 5.05060299610679, 1.4927180591674907, 'HP:0025031', 'Abnormality of the digestive system'),
(461031, 'HP:0004791', 'Esophageal ulceration', 'XPO:0141833', 'edematous alimentary system', 0.43902439024390244, 5.725717590856133, 1.5854745895265556, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461032, 'HP:0004791', 'Esophageal ulceration', 'XPO:0103009', 'abnormal manicotto glandulare morphology', 0.42857142857142855, 5.725717590856133, 1.5664861849086864, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461033, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101332', 'abnormal left spleen primordium', 0.40476190476190477, 7.4630184615845945, 1.7380292194851734, 'UPHENO:0002725', 'abnormal alimentary part of gastrointestinal system'),
(461034, 'HP:0004791', 'Esophageal ulceration', 'XPO:0142054', 'abnormal digestive tract', 0.4411764705882353, 5.05060299610679, 1.4927180591674907, 'HP:0025031', 'Abnormality of the digestive system'),
(461035, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102653', 'abnormal dorsal foregut morphology', 0.4090909090909091, 5.725717590856133, 1.5304701939081158, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461036, 'HP:0004791', 'Esophageal ulceration', 'XPO:0141308', 'abnormal esophageal epithelium morphology', 0.42857142857142855, 11.61213700143767, 2.23083619826138, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(461037, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101784', 'abnormal alimentary system morphology', 0.46153846153846156, 5.725717590856133, 1.6256195397716668, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(461038, 'HP:0004791', 'Esophageal ulceration', 'XPO:0102429', 'abnormal esophagus morphology', 0.46153846153846156, 11.61213700143767, 2.3150481305617356, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(461039, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101537', 'abnormal internal coil of the small intestine', 0.44, 8.037124161124119, 1.8805144591027776, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(461040, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101381', 'abnormal ventral foregut', 0.4166666666666667, 5.05060299610679, 1.45066119926208, 'HP:0025031', 'Abnormality of the digestive system'),
(461041, 'HP:0004791', 'Esophageal ulceration', 'XPO:0101377', 'abnormal manicotto glandulare', 0.42857142857142855, 5.05060299610679, 1.471238981671103, 'HP:0025031', 'Abnormality of the digestive system'),
(461042, 'HP:0003170', 'Abnormal acetabulum morphology', 'XPO:0101248', 'abnormal digit-joint region', 0.4126984126984127, 5.802924133159483, 1.547532739157473, 'UPHENO:0076727', 'abnormal limb bone morphology'),
(461043, 'HP:0003170', 'Abnormal acetabulum morphology', 'XPO:0100178', 'abnormal digit', 0.43333333333333335, 5.802924133159483, 1.5857491786857223, 'UPHENO:0076727', 'abnormal limb bone morphology'),
(461044, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100786', 'abnormal presumptive axial mesoderm', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461045, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100907', 'abnormal cytoplasm', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461046, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100104', 'abnormal embryonic structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461047, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101501', 'abnormal parabrachial area', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461048, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107265', 'abnormal posterior side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461049, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100427', 'abnormal olfactory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461050, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100231', 'abnormal compound organ', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461051, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100135', 'abnormal surface structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461052, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101553', 'abnormal dental epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461053, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100573', 'abnormal extraembryonic structure', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461054, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141900', 'abnormal mannose metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461055, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101519', 'abnormal hypobranchial placode', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461056, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461057, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100537', 'abnormal medium cavity', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461058, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100004', 'abnormal cell', 0.5238095238095238, 1.8210412618256888, 0.9766671675624242, 'HP:0000118', 'Phenotypic abnormality'),
(461059, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101366', 'abnormal morula cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461060, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141784', 'abnormal cellular hormone metabolic process', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461061, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100484', 'abnormal cement gland primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461062, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100784', 'abnormal left blastomere', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461063, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101264', 'abnormal mitotic spindle', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461064, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0142056', 'abnormal main body axis', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461065, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0115758', 'abnormally decreased mobility of melanoblast', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461066, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100196', 'abnormal neuron', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461067, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100546', 'abnormal whole organism', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461068, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100069', 'abnormal urinary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461069, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100394', 'abnormal marginal zone', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461070, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100610', 'abnormal appendage', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461071, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100416', 'abnormal ligament', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461072, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101174', 'abnormal articular system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461073, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141265', 'abnormal escape behavior', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461074, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100402', 'abnormal zeugopod', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461075, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101467', 'abnormal alkali secreting cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461076, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100337', 'abnormal zygote', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461077, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461078, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100688', 'abnormal adipose tissue', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461079, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141908', 'abnormal pyridine metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461080, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0126758', 'abnormally localised blood', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461081, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101176', 'abnormal non-ciliated epithelial cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461082, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141771', 'abnormal urea homeostasis', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461083, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100296', 'abnormal tail region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461084, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101061', 'abnormal plasma membrane', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461085, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100417', 'abnormal dense regular connective tissue', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461086, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141903', 'abnormal inositol phosphate metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461087, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101311', 'abnormal bottle cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461088, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100852', 'abnormal interdigital region', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461089, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131691', 'abnormal molecular function', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461090, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107260', 'abnormal anterior-posterior axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461091, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101468', 'abnormal stage I oocyte', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461092, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100557', 'abnormal prime meridian', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461093, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107285', 'abnormal flexural organ', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461094, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101411', 'abnormal marginal zone (sensu neural)', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461095, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101056', 'abnormal anterior ventral blood island', 0.48148148148148145, 5.574066539846944, 1.6382337487311942, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461096, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100133', 'abnormal solid compound organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461097, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141772', 'abnormal water homeostasis', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461098, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100103', 'abnormal trunk', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461099, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100444', 'abnormal cement gland', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461100, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461101, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141877', 'abnormal 2-deoxyribose 1-phosphate metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461102, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0102113', 'abnormal anatomical line morphology', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461103, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101480', 'abnormal stage V oocyte', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461104, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141263', 'abnormal visually guided collision avoidance behavior', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461105, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107324', 'abnormal embryonic thrombocyte', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461106, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100511', 'abnormal stylopod', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461107, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107261', 'abnormal dorsal-ventral axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461108, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0142052', 'abnormal nasal region', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461109, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0124923', 'absent hematological system', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461110, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100674', 'abnormal secondary oogonium', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461111, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100999', 'abnormal serous membrane', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461112, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101168', 'abnormal circulating cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461113, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141907', 'abnormal putrescine metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461114, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100202', 'abnormal embryo', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461115, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100295', 'abnormal extracellular matrix', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461116, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461117, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100827', 'abnormal atypical epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461118, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100515', 'abnormal somatic stem cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461119, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100273', 'abnormal visual system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461120, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100293', 'abnormal duct', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461121, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141884', 'abnormal phosphagen metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461122, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0115391', 'abnormally undifferentiated alimentary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461123, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100612', 'abnormal unilaminar epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461124, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131708', 'abnormal cilium disassembly', 0.41379310344827586, 4.758907843651163, 1.4032830240720355, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461125, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107284', 'abnormal migrating myoblast', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461126, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100894', 'abnormal nucleus', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461127, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100742', 'abnormal musculoskeletal system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461128, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107312', 'abnormal filopodium', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461129, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141789', 'abnormal hormone catabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461130, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101713', 'abnormal anatomical entity in vitro morphology', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461131, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100002', 'abnormal head', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461132, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461133, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100915', 'abnormal dermal system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461134, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107273', 'abnormal basal region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461135, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101573', 'abnormal peripheral vegetal yolk mass', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461136, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141910', 'abnormal D-ribose metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461137, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107268', 'abnormal left side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461138, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101098', 'abnormal mineralized extracellular matrix', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461139, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101435', 'abnormal paracrine cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461140, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100762', 'abnormal intersomitic region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461141, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100781', 'abnormal presumptive ectoderm', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461142, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100274', 'abnormal sensory system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461143, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100574', 'abnormal gastrula cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461144, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100599', 'abnormal adult immune system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461145, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100070', 'abnormal anatomical system', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461146, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100203', 'abnormal endocrine cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461147, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100991', 'abnormal iliac process primordium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461148, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107264', 'abnormal anterior side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461149, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461150, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100887', 'abnormal right-dorsal blastomere', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461151, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141271', 'increased surface breathing', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461152, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107276', 'abnormal dorsal region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461153, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100976', 'abnormal multiciliated cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461154, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461155, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100158', 'abnormal neuromere', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461156, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100386', 'abnormal limb', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461157, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101212', 'abnormal glomeral mesenchyme', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461158, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101113', 'abnormal stage IV oocyte', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461159, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107288', 'abnormal larval alimentary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461160, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100581', 'abnormal immune system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461161, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100843', 'abnormal fasciculated network of fibrils', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461162, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100724', 'abnormal kinetochore', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461163, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100308', 'abnormal early embryonic cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461164, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100653', 'abnormal myoblast', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461165, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101107', 'abnormal erythroid cell', 0.52, 5.574066539846944, 1.7025024524858727, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461166, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100377', 'abnormal connective tissue', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461167, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100989', 'abnormal right blastomere', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461168, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100727', 'abnormal odontogenic papilla', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461169, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461170, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100415', 'abnormal secretory epithelial cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461171, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100003', 'abnormal organism subdivision', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461172, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100429', 'abnormal spermatid', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461173, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107339', 'abnormal yolk platelet', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461174, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141880', 'abnormal ethanolamine metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461175, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100627', 'abnormal pharyngeal region', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461176, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0142051', 'abnormal cerebrospinal fluid', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461177, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141892', 'abnormal inositol metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461178, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141852', 'abnormal glucose metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461179, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101029', 'abnormal right spleen primordium', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461180, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100437', 'abnormal proepicardium', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461181, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100207', 'abnormal blastema', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461182, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100481', 'abnormal anatomical line', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461183, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101010', 'abnormal dorsal marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461184, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:00000000', 'Xenopus phenotype', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461185, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141798', 'abnormal lipid metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461186, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107278', 'abnormal medial region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461187, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100152', 'abnormal alimentary system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461188, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100916', 'abnormal principal cavity', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461189, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100393', 'abnormal involuting marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461190, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101378', 'abnormal blastomere D1', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461191, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100458', 'abnormal autopod', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461192, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100422', 'abnormal notochord', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461193, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101535', 'abnormal absorptive cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461194, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100796', 'abnormal pseudoblastema', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461195, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101497', 'abnormal ciliary axoneme', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461196, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100858', 'abnormal presumptive midbrain-hindbrain boundary', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461197, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100162', 'abnormal presumptive rhombomere', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461198, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141795', 'abnormal glycosylation', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461199, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131666', 'abnormal adherens junction', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461200, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107269', 'abnormal right side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461201, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100289', 'abnormal chondroblast', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461202, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107311', 'abnormal apical junction complex', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461203, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101472', 'abnormal zygote cortex', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461204, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101405', 'abnormal ring structure', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461205, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141777', 'abnormal catabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461206, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100339', 'abnormal circumblastoporal collar', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461207, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141790', 'abnormal cellular metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461208, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100802', 'abnormal exocrine cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461209, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131706', 'abnormal ciliary basal body organization', 0.41379310344827586, 4.758907843651163, 1.4032830240720355, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461210, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100704', 'abnormal Merkel cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461211, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101513', 'abnormal basal body', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461212, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100032', 'abnormal nervous system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461213, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461214, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100707', 'abnormal central vegetal yolk mass', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461215, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461216, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101498', 'abnormal stage II oocyte', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461217, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100868', 'abnormal transporting epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461218, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100667', 'abnormal vegetal yolk mass', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461219, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141796', 'abnormal demethylation', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461220, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100588', 'abnormal unicellular gland', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461221, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101450', 'abnormal myeloid cell', 0.52, 5.574066539846944, 1.7025024524858727, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461222, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0142054', 'abnormal digestive tract', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461223, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107258', 'abnormal anatomical axis', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461224, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101389', 'abnormal wedge region', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461225, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100277', 'abnormal blastocoel', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461226, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141794', 'abnormal prosthetic group metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461227, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101078', 'abnormal mucous gland', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461228, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100673', 'abnormal anterior dorsal lateral plate region', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461229, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100014', 'abnormal tissue', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461230, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100186', 'abnormal uveal tract', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461231, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100501', 'abnormal urogenital system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461232, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100902', 'abnormal spermatocyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461233, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107267', 'abnormal ventral side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461234, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0102455', 'abnormal blood morphology', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461235, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100551', 'abnormal oocyte cortex', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461236, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100201', 'abnormal cavitated compound organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461237, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141781', 'abnormal secondary metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461238, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101109', 'abnormal egg cell-free extract', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461239, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141860', 'abnormal malate-aspartate shuttle', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461240, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100638', 'abnormal polar body', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461241, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100392', 'abnormal cilium', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461242, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101406', 'abnormal cleavage furrow', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461243, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101202', 'abnormal thymus', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461244, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100261', 'abnormal multilaminar epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461245, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100900', 'abnormal angioblast', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461246, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101570', 'abnormal forelimb region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461247, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141748', 'abnormal gas homeostasis', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461248, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141315', 'abnormal anatomical region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461249, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461250, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461251, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100026', 'abnormal germ cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461252, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141792', 'abnormal small molecule metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461253, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100917', 'abnormal stage III oocyte', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461254, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100151', 'abnormal primordium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461255, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141911', 'abnormal ribose phosphate metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461256, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461257, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100547', 'abnormal blastomere V2', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461258, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100956', 'abnormal centrosome', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461259, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101362', 'abnormal vegetal cortex', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461260, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101072', 'abnormal mitochondrial cloud', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461261, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101136', 'abnormal ooplasm', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461262, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101237', 'abnormal mucus secreting cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461263, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0116494', 'absent biological process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461264, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107266', 'abnormal dorsal side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461265, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100585', 'abnormal elastica externa', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461266, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100465', 'abnormal skeletal system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461267, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100728', 'abnormal cell condensation', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461268, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461269, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101638', 'abnormal anatomical structure morphology', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461270, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101484', 'abnormal bone marrow', 0.4482758620689655, 5.574066539846944, 1.5807338433081215, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461271, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141854', 'abnormal glutathione metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461272, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100890', 'abnormal pharyngeal cavity', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461273, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100009', 'abnormal multi-tissue structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461274, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100084', 'abnormal anatomical group', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461275, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100006', 'abnormal anatomical structure', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461276, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0142057', 'abnormal desmosome', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461277, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100268', 'abnormal circulatory system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461278, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100912', 'abnormal trabecula', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461279, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100258', 'abnormal organ part', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461280, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100307', 'abnormal blastomere', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461281, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101221', 'abnormal larval immune system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461282, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101004', 'abnormal acid secreting cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461283, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101326', 'abnormal cementoblast', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461284, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100823', 'abnormal blood', 0.5652173913043478, 5.574066539846944, 1.7749815065541226, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461285, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101302', 'abnormal subcortical cytoplasm', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461286, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141864', 'abnormal 5-methylcytosine metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461287, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100807', 'abnormal matrix-based tissue', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461288, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100062', 'abnormal anatomical space', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461289, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100856', 'abnormal simple organ', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461290, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100509', 'abnormal germ plasm', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461291, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141276', 'decreased surface breathing', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461292, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100531', 'abnormal proliferative region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461293, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100028', 'abnormal anatomical cluster', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461294, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101543', 'abnormal external gill', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461295, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461296, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141786', 'abnormal pigment metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461297, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100503', 'abnormal blastomere D2', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461298, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100176', 'abnormal stage VI oocyte', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461299, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131675', 'abnormal spindle microtubule', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461300, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141782', 'abnormal methylation', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461301, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100067', 'abnormal animal hemisphere', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461302, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461303, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100626', 'abnormal primordial germ cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461304, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100493', 'abnormal liver and biliary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461305, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0116434', 'abnormal biological process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461306, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461307, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101560', 'abnormal compound organ component', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461308, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107263', 'abnormal anatomical side', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461309, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131677', 'abnormal actin filament', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461310, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100285', 'abnormal progenitor cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461311, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100317', 'abnormal respiratory system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461312, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100468', 'abnormal muscular system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461313, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100842', 'abnormal left-dorsal blastomere', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461314, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131669', 'abnormal Roux spot', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461315, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141787', 'abnormal hormone metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461316, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101976', 'abnormal portion of organism substance morphology', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461317, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141775', 'abnormal nitrogen compound metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461318, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100553', 'abnormal laryngeal muscle primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461319, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100715', 'abnormal ciliated cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461320, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461321, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101587', 'abnormal hemangioblast', 0.52, 5.574066539846944, 1.7025024524858727, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461322, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100477', 'abnormal pericyte', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461323, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101463', 'abnormal right-ventral blastomere', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461324, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100846', 'abnormal hindlimb', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461325, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101023', 'abnormal ultimobranchial body', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461326, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107253', 'abnormal enteric nervous system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461327, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100913', 'abnormal Brachets cleft', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461328, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107272', 'abnormal axial region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461329, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101040', 'abnormal axial mesoderm', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461330, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101220', 'abnormal centriole', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461331, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100640', 'abnormal notochordal sheath', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461332, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100120', 'abnormal genital system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461333, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100482', 'abnormal Mullerian duct', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461334, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101451', 'abnormal dorsal lymph space', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461335, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100309', 'abnormal vegetal hemisphere', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461336, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107325', 'abnormal adult thrombocyte', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461337, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100545', 'abnormal male organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461338, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100225', 'abnormal endocrine system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461339, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461340, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101461', 'abnormal sperm entry point', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461341, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100218', 'abnormal epithelial cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461342, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100722', 'abnormal barbel', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461343, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100816', 'abnormal blastocoel anlage', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461344, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100025', 'abnormal oocyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461345, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100232', 'abnormal lymphatic system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461346, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100862', 'abnormal blastomere V1', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461347, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100754', 'abnormal electrically active cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461348, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131687', 'abnormal astral microtubule', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461349, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461350, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100192', 'abnormal epithelium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461351, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101283', 'abnormal left-ventral blastomere', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461352, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101188', 'abnormal posterior ventral blood island', 0.48148148148148145, 5.574066539846944, 1.6382337487311942, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461353, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100888', 'abnormal microtubule', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461354, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101297', 'abnormal barrier cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461355, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100449', 'abnormal lymphocyte', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461356, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100854', 'abnormal spiracle', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461357, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100175', 'abnormal migrating neuroblast', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461358, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461359, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141272', 'absent surface breathing', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461360, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141267', 'abnormal resting posture', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461361, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141776', 'abnormal metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461362, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100643', 'abnormal thoracic region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461363, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141898', 'abnormal maltose metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461364, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100363', 'abnormal cardiovascular system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461365, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141743', 'abnormal chemical homeostasis within a tissue', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461366, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101347', 'abnormal hindlimb region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461367, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141883', 'abnormal glycerol metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461368, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101224', 'abnormal dorsal involuting marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461369, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101409', 'abnormal perivitelline space', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461370, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141497', 'abnormal lymphoblast', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461371, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101503', 'abnormal organ cortex', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461372, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100251', 'abnormal proteinaceous extracellular matrix', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461373, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101092', 'abnormal dorso-lateral marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461374, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141797', 'abnormal hydrogen metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461375, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100533', 'abnormal melanoblast', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461376, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100616', 'abnormal ventral blood island', 0.5, 5.574066539846944, 1.6694410052240456, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461377, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101099', 'abnormal ventro-lateral marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461378, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101132', 'abnormal apoptotic cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461379, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100265', 'abnormal sensory epithelial cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461380, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100642', 'abnormal gustatory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461381, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107270', 'abnormal proximal-distal axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461382, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100372', 'abnormal hematological system', 0.6190476190476191, 5.574066539846944, 1.85758246651535, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461383, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101157', 'abnormal female organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461384, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141714', 'abnormal anterior notochord', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461385, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101200', 'abnormal joint region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461386, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100745', 'abnormal anterior lymph sac', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461387, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141850', 'abnormal galactose metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461388, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141788', 'abnormal hormone biosynthetic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461389, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100060', 'abnormal regenerating tissue', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461390, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461391, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100403', 'abnormal forelimb', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461392, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100114', 'abnormal peripheral nervous system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461393, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100800', 'abnormal ventral marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461394, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100702', 'abnormal glial cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461395, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0102004', 'abnormal hematological system morphology', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461396, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107271', 'abnormal apical region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461397, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0125135', 'absent blood', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461398, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141859', 'abnormal lactose catabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461399, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100378', 'abnormal perichondrium', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461400, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101149', 'abnormal amputated limb', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461401, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101074', 'abnormal germinal vesicle', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461402, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100344', 'abnormal portion of organism substance', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461403, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141264', 'abnormal schooling behavior', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461404, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141499', 'abnormal tadpole', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461405, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101424', 'abnormal coelomic epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461406, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101141', 'abnormal Keller explant', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461407, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100164', 'abnormal neural nucleus', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461408, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141767', 'abnormal temperature homeostasis', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461409, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100249', 'abnormal avascular GAG-rich matrix', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461410, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100587', 'abnormal vestibuloauditory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461411, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141881', 'abnormal fructose metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461412, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461413, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100031', 'abnormal central nervous system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(461414, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0115505', 'dead whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461415, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141715', 'abnormal septum', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461416, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107262', 'abnormal left-right axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461417, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100549', 'abnormal mitotic cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461418, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100108', 'abnormal cell part', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461419, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141783', 'abnormal collagen metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461420, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100665', 'abnormal egg jelly', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461421, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141841', 'abnormality of whole organism mass', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461422, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100384', 'abnormal amputated tissue', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461423, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100721', 'abnormal centromere', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461424, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100935', 'abnormal skeleton', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(461425, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141791', 'abnormal primary metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461426, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141718', 'abnormal posterior notochord', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461427, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101096', 'abnormal tendon', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(461428, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101575', 'abnormal vitelline membrane', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461429, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100172', 'abnormal stem cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(461430, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141778', 'abnormal biosynthetic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461431, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461432, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141770', 'abnormal urate homeostasis', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461433, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100023', 'abnormal mesenchyme', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461434, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100205', 'abnormal limb segment', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(461435, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100282', 'abnormal pelvic girdle primordium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461436, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100383', 'abnormal amputated fin', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461437, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141266', 'abnormal surface breathing', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461438, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100423', 'abnormal process', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461439, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100256', 'abnormal paired appendage', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461440, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141904', 'abnormal glucosamine metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461441, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0131694', 'abnormal RNA polymerase II activity', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461442, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101349', 'abnormal trunk region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461443, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0126537', 'abnormally localised hematological system', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461444, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101577', 'abnormal notochordal epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461445, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0141745', 'abnormal creatinine homeostasis', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461446, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0107323', 'abnormal thrombocyte', 0.4482758620689655, 5.574066539846944, 1.5807338433081215, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461447, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0100605', 'abnormal prechordal plate', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461448, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101110', 'abnormal cell-free extract', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(461449, 'HP:0032180', 'Abnormal circulating metabolite concentration', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(461450, 'HP:0034006', 'Decreased urinary lysyl-pyridinoline-hydroxylysyl-pyridinoline ratio', 'XPO:0100501', 'abnormal urogenital system', 0.43333333333333335, 5.4478002382576385, 1.5364613358553185, 'HP:0000119', 'Abnormality of the genitourinary system'),
(461451, 'HP:0034006', 'Decreased urinary lysyl-pyridinoline-hydroxylysyl-pyridinoline ratio', 'XPO:0101701', 'abnormal urinary system morphology', 0.41025641025641024, 6.355235291121788, 1.61470617044417, 'HP:0000079', 'Abnormality of the urinary system'),
(461452, 'HP:0034006', 'Decreased urinary lysyl-pyridinoline-hydroxylysyl-pyridinoline ratio', 'XPO:0126535', 'abnormally localised urinary system', 0.41025641025641024, 6.355235291121788, 1.61470617044417, 'HP:0000079', 'Abnormality of the urinary system'),
(461453, 'HP:0034006', 'Decreased urinary lysyl-pyridinoline-hydroxylysyl-pyridinoline ratio', 'XPO:0100069', 'abnormal urinary system', 0.4838709677419355, 6.355235291121788, 1.7536002539184354, 'HP:0000079', 'Abnormality of the urinary system'),
(461454, 'HP:0034006', 'Decreased urinary lysyl-pyridinoline-hydroxylysyl-pyridinoline ratio', 'XPO:0100085', 'abnormal mesonephric sinus', 0.4166666666666667, 6.355235291121788, 1.6272721667361236, 'HP:0000079', 'Abnormality of the urinary system'),
(461455, 'HP:0410373', 'Abnormal proportion of naive CD4 T cells', 'XPO:0131005', 'abnormally increased number of thymocyte', 0.4423076923076923, 9.586341000560333, 2.0591533128041863, 'HP:0011839', 'Abnormal T cell count'),
(461456, 'HP:0410373', 'Abnormal proportion of naive CD4 T cells', 'XPO:0125284', 'absent thymocyte', 0.4842105263157895, 9.586341000560333, 2.1544853727338116, 'HP:0011839', 'Abnormal T cell count'),
(461457, 'HP:0410373', 'Abnormal proportion of naive CD4 T cells', 'XPO:0131221', 'abnormally decreased number of thymocyte', 0.4380952380952381, 9.586341000560333, 2.049324362589442, 'HP:0011839', 'Abnormal T cell count'),
(461458, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0100002', 'abnormal head', 0.4166666666666667, 3.868794716113063, 1.2696447528267278, 'UPHENO:0002844', 'abnormal head'),
(461459, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0100627', 'abnormal pharyngeal region', 0.40540540540540543, 3.868794716113063, 1.2523698696136485, 'UPHENO:0002844', 'abnormal head'),
(461460, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0101173', 'abnormal retinal layer', 0.4666666666666667, 6.02624522851634, 1.6769757819681315, 'HP:0000478', 'Abnormality of the eye'),
(461461, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0101578', 'abnormal pupil', 0.42, 6.02624522851634, 1.590918915588366, 'HP:0000478', 'Abnormality of the eye'),
(461462, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0127803', 'abnormally localised retinal layer', 0.4074074074074074, 6.02624522851634, 1.5668876618797856, 'HP:0000478', 'Abnormality of the eye'),
(461463, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0100918', 'abnormal lens', 0.42857142857142855, 6.02624522851634, 1.6070707907578319, 'HP:0000478', 'Abnormality of the eye'),
(461464, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0101230', 'abnormal iris', 0.4117647058823529, 6.02624522851634, 1.5752444553449358, 'HP:0000478', 'Abnormality of the eye'),
(461465, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0100485', 'abnormal retina', 0.42857142857142855, 6.02624522851634, 1.6070707907578319, 'HP:0000478', 'Abnormality of the eye'),
(461466, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0101416', 'abnormal cornea', 0.42, 6.02624522851634, 1.590918915588366, 'HP:0000478', 'Abnormality of the eye'),
(461467, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0142052', 'abnormal nasal region', 0.4166666666666667, 3.868794716113063, 1.2696447528267278, 'UPHENO:0002844', 'abnormal head'),
(461468, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0101390', 'abnormal ciliary body', 0.4117647058823529, 6.02624522851634, 1.5752444553449358, 'HP:0000478', 'Abnormality of the eye'),
(461469, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0101289', 'abnormal orbital region', 0.41304347826086957, 5.757493499662858, 1.5421073701805246, 'HP:0000315', 'Abnormality of the orbital region'),
(461470, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0101554', 'abnormal peripheral retina', 0.42, 6.02624522851634, 1.590918915588366, 'HP:0000478', 'Abnormality of the eye'),
(461471, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0100727', 'abnormal odontogenic papilla', 0.40540540540540543, 3.868794716113063, 1.2523698696136485, 'UPHENO:0002844', 'abnormal head'),
(461472, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0100564', 'abnormal central retina', 0.42, 6.02624522851634, 1.590918915588366, 'HP:0000478', 'Abnormality of the eye'),
(461473, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0100844', 'abnormal lens transitional zone', 0.4117647058823529, 6.02624522851634, 1.5752444553449358, 'HP:0000478', 'Abnormality of the eye'),
(461474, 'HP:0007928', 'Abnormal flash visual evoked potentials', 'XPO:0100881', 'abnormal sclera', 0.42857142857142855, 6.02624522851634, 1.6070707907578319, 'HP:0000478', 'Abnormality of the eye'),
(461475, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0115526', 'abnormally incomplete structure of head', 0.42857142857142855, 4.5318002188002176, 1.3936283915633758, 'UPHENO:0087907', 'abnormal head morphology'),
(461476, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0103358', 'decreased size of the pharyngeal region', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(461477, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0142059', 'abnormal nasal region morphology', 0.42857142857142855, 4.5318002188002176, 1.3936283915633758, 'UPHENO:0087907', 'abnormal head morphology'),
(461478, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0141339', 'decreased pigmentation in the head', 0.4117647058823529, 4.5318002188002176, 1.3660290568695288, 'UPHENO:0087907', 'abnormal head morphology'),
(461479, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0102804', 'abnormal pharyngeal pouch morphology', 0.4117647058823529, 4.5318002188002176, 1.3660290568695288, 'UPHENO:0087907', 'abnormal head morphology'),
(461480, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0103739', 'increased size of the pharyngeal region', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(461481, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0140335', 'abnormally necrotic pharyngeal region', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(461482, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0102224', 'abnormal auditory apparatus morphology', 0.4166666666666667, 7.26295268789559, 1.7396063596754188, 'UPHENO:0076730', 'abnormal ear morphology'),
(461483, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0141839', 'edematous pharyngeal region', 0.42857142857142855, 4.5318002188002176, 1.3936283915633758, 'UPHENO:0087907', 'abnormal head morphology'),
(461484, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0102082', 'abnormal circumpharyngeal ridge morphology', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(461485, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0103707', 'increased pigmentation in the head', 0.4117647058823529, 4.5318002188002176, 1.3660290568695288, 'UPHENO:0087907', 'abnormal head morphology'),
(461486, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0102538', 'abnormal lateral nasal prominence morphology', 0.4117647058823529, 4.5318002188002176, 1.3660290568695288, 'UPHENO:0087907', 'abnormal head morphology'),
(461487, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0141298', 'abnormal intercanthal region morphology', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(461488, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0102259', 'abnormal pharyngeal region morphology', 0.44680851063829785, 4.5318002188002176, 1.422971154406314, 'UPHENO:0087907', 'abnormal head morphology'),
(461489, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0126939', 'abnormally localised auditory apparatus', 0.515625, 10.484129389061598, 2.3250546695152967, 'UPHENO:0005986', 'abnormal shape of external ear'),
(461490, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0101634', 'abnormal head morphology', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(461491, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0103101', 'abnormal medial nasal prominence morphology', 0.4117647058823529, 4.5318002188002176, 1.3660290568695288, 'UPHENO:0087907', 'abnormal head morphology'),
(461492, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0102734', 'abnormal craniofacial region morphology', 0.4117647058823529, 4.5318002188002176, 1.3660290568695288, 'UPHENO:0087907', 'abnormal head morphology'),
(461493, 'HP:0011239', 'Underdeveloped inferior crus of antihelix', 'XPO:0141835', 'edematous head', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(461494, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0133370', 'olfactory pit fused with brain', 0.417910447761194, 5.788671267106304, 1.5553604730668558, 'UPHENO:0087472', 'abnormal face morphology'),
(461495, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129780', 'increased size of the retina', 0.5584415584415584, 8.040873045973026, 2.1190464070010115, 'HP:0000479', 'Abnormal retinal morphology'),
(461496, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128643', 'decreased size of the retinal layer', 0.5733333333333334, 8.040873045973026, 2.147114469784475, 'HP:0000479', 'Abnormal retinal morphology'),
(461497, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140620', 'abnormally necrotic horizontal cell', 0.46236559139784944, 8.040873045973026, 1.9281657141584967, 'HP:0000479', 'Abnormal retinal morphology'),
(461498, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103186', 'abnormal peripheral retina morphology', 0.589041095890411, 8.040873045973026, 2.1763282544036455, 'HP:0000479', 'Abnormal retinal morphology'),
(461499, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0101359', 'abnormal hyaloid artery', 0.4430379746835443, 6.887869297006056, 1.7468794071802813, 'HP:0012372', 'Abnormal eye morphology'),
(461500, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129741', 'increased size of the optic fiber layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461501, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130285', 'increased size of the lens transitional zone', 0.4166666666666667, 6.887869297006056, 1.6940913612964297, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461502, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0101861', 'abnormal photoreceptor layer morphology', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(461503, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102450', 'abnormal retinal stem cell morphology', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(461504, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140250', 'abnormally necrotic iris', 0.4069767441860465, 6.887869297006056, 1.6742767456052652, 'HP:0012372', 'Abnormal eye morphology'),
(461505, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129947', 'increased size of the lens', 0.42168674698795183, 6.887869297006056, 1.7042661756699493, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461506, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130148', 'increased size of the ciliary marginal zone', 0.48863636363636365, 8.040873045973026, 1.982186410418029, 'HP:0000479', 'Abnormal retinal morphology'),
(461507, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129580', 'increased size of the inner limiting membrane', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461508, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130048', 'increased size of the optic disc', 0.4246575342465753, 6.575878401988876, 1.6710763919384135, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461509, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128475', 'decreased size of the retinal stem cell region', 0.5443037974683544, 8.040873045973026, 2.0920510830006163, 'HP:0000479', 'Abnormal retinal morphology'),
(461510, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128807', 'decreased size of the lens transitional zone', 0.4166666666666667, 6.887869297006056, 1.6940913612964297, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461511, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129810', 'increased size of the retinal progenitor cell region', 0.5443037974683544, 8.040873045973026, 2.0920510830006163, 'HP:0000479', 'Abnormal retinal morphology'),
(461512, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102784', 'abnormal retinal progenitor cell region morphology', 0.581081081081081, 8.040873045973026, 2.1615733164502497, 'HP:0000479', 'Abnormal retinal morphology'),
(461513, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130539', 'increased size of the ciliary body', 0.40229885057471265, 6.887869297006056, 1.6646266551675757, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461514, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128330', 'decreased size of the retinal progenitor cell region', 0.5443037974683544, 8.040873045973026, 2.0920510830006163, 'HP:0000479', 'Abnormal retinal morphology'),
(461515, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130863', 'increased size of the sclera', 0.4430379746835443, 6.887869297006056, 1.7468794071802813, 'HP:0012372', 'Abnormal eye morphology'),
(461516, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140948', 'abnormally necrotic retinal inner nuclear layer', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461517, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130257', 'increased size of the retinal blood vessel', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(461518, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129371', 'decreased size of the retinal outer plexiform layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461519, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128200', 'decreased size of the retinal rod cell', 0.4215686274509804, 8.040873045973026, 1.8411354685352277, 'HP:0000479', 'Abnormal retinal morphology'),
(461520, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128491', 'decreased size of the retinal ganglion cell', 0.4174757281553398, 8.040873045973026, 1.8321761186829812, 'HP:0000479', 'Abnormal retinal morphology'),
(461521, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128669', 'decreased size of the ciliary marginal zone', 0.48863636363636365, 8.040873045973026, 1.982186410418029, 'HP:0000479', 'Abnormal retinal morphology'),
(461522, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130906', 'increased size of the retinal stem cell', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(461523, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141138', 'abnormally necrotic retinal inner plexiform layer', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461524, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102232', 'abnormal eye photoreceptor cell morphology', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(461525, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0139887', 'abnormally necrotic Muller cell', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(461526, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130125', 'increased size of the outer limiting membrane', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461527, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103376', 'increased size of the eye', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'HP:0012372', 'Abnormal eye morphology'),
(461528, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140491', 'abnormally necrotic retinal rod cell', 0.4574468085106383, 8.040873045973026, 1.9178820903589395, 'HP:0000479', 'Abnormal retinal morphology'),
(461529, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140375', 'abnormally necrotic lens', 0.4375, 6.887869297006056, 1.7359270772241988, 'HP:0012372', 'Abnormal eye morphology'),
(461530, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129083', 'decreased size of the bipolar neuron', 0.4095238095238095, 8.040873045973026, 1.8146429295275122, 'HP:0000479', 'Abnormal retinal morphology'),
(461531, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141014', 'abnormally necrotic retinal outer plexiform layer', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461532, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129911', 'increased size of the retinal inner nuclear layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461533, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130413', 'increased size of the central retina', 0.5733333333333334, 8.040873045973026, 2.147114469784475, 'HP:0000479', 'Abnormal retinal morphology'),
(461534, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129258', 'decreased size of the amacrine cell', 0.4095238095238095, 8.040873045973026, 1.8146429295275122, 'HP:0000479', 'Abnormal retinal morphology'),
(461535, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140391', 'abnormally necrotic central retina', 0.589041095890411, 8.040873045973026, 2.1763282544036455, 'HP:0000479', 'Abnormal retinal morphology'),
(461536, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0101315', 'abnormal hyaloid vascular plexus', 0.4492753623188406, 6.887869297006056, 1.759133301946505, 'HP:0012372', 'Abnormal eye morphology'),
(461537, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128431', 'decreased size of the retinal inner nuclear layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461538, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141033', 'abnormally necrotic photoreceptor layer', 0.4777777777777778, 8.040873045973026, 1.960038381077836, 'HP:0000479', 'Abnormal retinal morphology'),
(461539, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128100', 'decreased size of the inner limiting membrane', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461540, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102939', 'abnormal retinal ganglion cell layer morphology', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461541, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140346', 'abnormally necrotic retinal blood vessel', 0.4574468085106383, 8.040873045973026, 1.9178820903589395, 'HP:0000479', 'Abnormal retinal morphology'),
(461542, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129680', 'increased size of the retinal rod cell', 0.4215686274509804, 8.040873045973026, 1.8411354685352277, 'HP:0000479', 'Abnormal retinal morphology'),
(461543, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130761', 'increased size of the retinal inner plexiform layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461544, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0100710', 'abnormal hyaloid vein', 0.4492753623188406, 6.887869297006056, 1.759133301946505, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461545, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130506', 'increased size of the Muller cell', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461546, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128467', 'decreased size of the lens', 0.42168674698795183, 6.887869297006056, 1.7042661756699493, 'HP:0012372', 'Abnormal eye morphology'),
(461547, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102266', 'abnormal horizontal cell morphology', 0.48863636363636365, 8.040873045973026, 1.982186410418029, 'HP:0000479', 'Abnormal retinal morphology'),
(461548, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0115423', 'abnormally incomplete structure of eye', 0.4861111111111111, 6.887869297006056, 1.8298278053291577, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461549, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128295', 'decreased size of the retinal neural layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461550, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140869', 'abnormally necrotic optic chiasm', 0.4659090909090909, 7.796308075334707, 1.90587796246937, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(461551, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102513', 'abnormal sclera morphology', 0.4861111111111111, 6.887869297006056, 1.8298278053291577, 'HP:0012372', 'Abnormal eye morphology'),
(461552, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128884', 'decreased size of the retinal pigmented epithelium', 0.46236559139784944, 8.040873045973026, 1.9281657141584967, 'HP:0000479', 'Abnormal retinal morphology'),
(461553, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130122', 'increased size of the retinal layer', 0.5733333333333334, 8.040873045973026, 2.147114469784475, 'HP:0000479', 'Abnormal retinal morphology'),
(461554, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102017', 'abnormal retinal neural layer morphology', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(461555, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140671', 'abnormally necrotic retinal ganglion cell', 0.45263157894736844, 8.040873045973026, 1.9077612698957138, 'HP:0000479', 'Abnormal retinal morphology'),
(461556, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102851', 'abnormal retinal rod cell morphology', 0.48314606741573035, 8.040873045973026, 1.9710190741722953, 'HP:0000479', 'Abnormal retinal morphology'),
(461557, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140808', 'abnormally necrotic retinal cone cell', 0.4574468085106383, 8.040873045973026, 1.9178820903589395, 'HP:0000479', 'Abnormal retinal morphology'),
(461558, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102239', 'abnormal retinal pigmented epithelium morphology', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461559, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130560', 'increased size of the bipolar neuron', 0.4095238095238095, 8.040873045973026, 1.8146429295275122, 'HP:0000479', 'Abnormal retinal morphology'),
(461560, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103336', 'decreased size of the eye', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461561, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140538', 'abnormally necrotic optic disc', 0.43661971830985913, 6.575878401988876, 1.6944492248268372, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461562, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141343', 'decreased pigmentation in the eye', 0.47297297297297297, 6.887869297006056, 1.8049310288357878, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461563, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130265', 'increased size of the peripheral retina', 0.5308641975308642, 8.040873045973026, 2.066061861851679, 'HP:0000479', 'Abnormal retinal morphology'),
(461564, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140797', 'abnormally necrotic bipolar neuron', 0.44329896907216493, 8.040873045973026, 1.8879911895239345, 'HP:0000479', 'Abnormal retinal morphology'),
(461565, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140240', 'abnormally necrotic eye photoreceptor cell', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461566, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102117', 'abnormal retina morphology', 0.6142857142857143, 8.040873045973026, 2.2224746213458295, 'HP:0000479', 'Abnormal retinal morphology'),
(461567, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128779', 'decreased size of the retinal blood vessel', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(461568, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129981', 'increased size of the retinal ganglion cell layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461569, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140473', 'abnormally necrotic lens transitional zone', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461570, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0133354', 'fused eyes', 0.47297297297297297, 6.887869297006056, 1.8049310288357878, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461571, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140520', 'abnormally necrotic retinal outer nuclear layer', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461572, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130614', 'increased size of the retinal progenitor cell', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(461573, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140945', 'abnormally necrotic retinal ganglion cell layer', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461574, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103706', 'increased pigmentation in the optic nerve', 0.41, 7.796308075334707, 1.7878720062933, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(461575, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141638', 'neoplastic eye', 0.47297297297297297, 6.887869297006056, 1.8049310288357878, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461576, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103814', 'decreased length of axon in retinal ganglion cell', 0.4215686274509804, 8.040873045973026, 1.8411354685352277, 'HP:0000479', 'Abnormal retinal morphology'),
(461577, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103022', 'abnormal ciliary body morphology', 0.4430379746835443, 6.887869297006056, 1.7468794071802813, 'HP:0012372', 'Abnormal eye morphology'),
(461578, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0125909', 'absent retinal blood vessel', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461579, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140218', 'abnormally necrotic sclera', 0.45454545454545453, 6.887869297006056, 1.769420718895678, 'HP:0012372', 'Abnormal eye morphology'),
(461580, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102805', 'abnormal retinal layer morphology', 0.6323529411764706, 8.040873045973026, 2.2549212226256703, 'HP:0000479', 'Abnormal retinal morphology'),
(461581, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103160', 'abnormal choroid morphology', 0.4305555555555556, 6.575878401988876, 1.6826410724316994, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461582, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102862', 'abnormal iris morphology', 0.43209876543209874, 6.887869297006056, 1.7251781994025936, 'HP:0012372', 'Abnormal eye morphology'),
(461583, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141323', 'edematous eye', 0.4794520547945205, 6.887869297006056, 1.81725152018251, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461584, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0101823', 'abnormal lens epithelium morphology', 0.4166666666666667, 6.887869297006056, 1.6940913612964297, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461585, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0115417', 'abnormally wholly ventralized eye', 0.44871794871794873, 6.887869297006056, 1.7580416894914344, 'HP:0012372', 'Abnormal eye morphology'),
(461586, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102963', 'abnormal retinal outer nuclear layer morphology', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461587, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0133369', 'eye fused with brain', 0.47297297297297297, 6.887869297006056, 1.8049310288357878, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461588, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102581', 'abnormal outer limiting membrane morphology', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461589, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140489', 'abnormally necrotic ciliary marginal zone', 0.5, 8.040873045973026, 2.0051026215599324, 'HP:0000479', 'Abnormal retinal morphology'),
(461590, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103226', 'abnormal retinal outer plexiform layer morphology', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461591, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102505', 'abnormal retinal stem cell region morphology', 0.581081081081081, 8.040873045973026, 2.1615733164502497, 'HP:0000479', 'Abnormal retinal morphology'),
(461592, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141182', 'abnormally necrotic inner limiting membrane', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461593, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129775', 'increased size of the retinal neural layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461594, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0139731', 'abnormally necrotic eye', 0.44871794871794873, 6.887869297006056, 1.7580416894914344, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461595, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0107252', 'decreased size of the globe', 0.4025974025974026, 6.575878401988876, 1.627092979653308, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461596, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141141', 'abnormally necrotic cornea', 0.4117647058823529, 6.887869297006056, 1.6840966347682629, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461597, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128568', 'decreased size of the optic disc', 0.4246575342465753, 6.575878401988876, 1.6710763919384135, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461598, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141337', 'increased pigmentation in the eye', 0.47297297297297297, 6.887869297006056, 1.8049310288357878, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461599, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0133371', 'eye fused with olfactory pit', 0.47297297297297297, 6.887869297006056, 1.8049310288357878, 'HP:0012372', 'Abnormal eye morphology'),
(461600, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103110', 'abnormal lens fiber cell mass morphology', 0.40229885057471265, 6.887869297006056, 1.6646266551675757, 'HP:0012372', 'Abnormal eye morphology'),
(461601, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102550', 'abnormal lens morphology', 0.4666666666666667, 6.887869297006056, 1.7928577760852904, 'HP:0012372', 'Abnormal eye morphology'),
(461602, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128201', 'decreased size of the eye photoreceptor cell', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(461603, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130734', 'increased size of the amacrine cell', 0.4095238095238095, 8.040873045973026, 1.8146429295275122, 'HP:0000479', 'Abnormal retinal morphology'),
(461604, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128300', 'decreased size of the retina', 0.5584415584415584, 8.040873045973026, 2.1190464070010115, 'HP:0000479', 'Abnormal retinal morphology'),
(461605, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128599', 'decreased size of the olfactory pit', 0.4057971014492754, 5.788671267106304, 1.532653261972336, 'UPHENO:0087472', 'abnormal face morphology'),
(461606, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141338', 'decreased pigmentation in the optic nerve', 0.41, 7.796308075334707, 1.7878720062933, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(461607, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128261', 'decreased size of the optic fiber layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461608, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130001', 'increased size of the horizontal cell', 0.42574257425742573, 8.040873045973026, 1.850227550835222, 'HP:0000479', 'Abnormal retinal morphology'),
(461609, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130362', 'increased size of the retinal pigmented epithelium', 0.46236559139784944, 8.040873045973026, 1.9281657141584967, 'HP:0000479', 'Abnormal retinal morphology'),
(461610, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103210', 'abnormal pupil morphology', 0.43209876543209874, 6.887869297006056, 1.7251781994025936, 'HP:0012372', 'Abnormal eye morphology'),
(461611, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102831', 'abnormal optic disc morphology', 0.45588235294117646, 6.575878401988876, 1.7314233793482612, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461612, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102476', 'abnormal lens transitional zone morphology', 0.45454545454545453, 6.887869297006056, 1.769420718895678, 'HP:0012372', 'Abnormal eye morphology'),
(461613, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128848', 'decreased size of the retinal cone cell', 0.4215686274509804, 8.040873045973026, 1.8411354685352277, 'HP:0000479', 'Abnormal retinal morphology'),
(461614, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128501', 'decreased size of the retinal ganglion cell layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461615, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129971', 'increased size of the retinal ganglion cell', 0.4174757281553398, 8.040873045973026, 1.8321761186829812, 'HP:0000479', 'Abnormal retinal morphology'),
(461616, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102196', 'abnormal central retina morphology', 0.6142857142857143, 8.040873045973026, 2.2224746213458295, 'HP:0000479', 'Abnormal retinal morphology'),
(461617, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140271', 'abnormally necrotic peripheral retina', 0.5443037974683544, 8.040873045973026, 2.0920510830006163, 'HP:0000479', 'Abnormal retinal morphology'),
(461618, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141333', 'increased pigmentation in the retinal pigmented epithelium', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(461619, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103184', 'abnormal inner limiting membrane morphology', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461620, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102756', 'abnormal Muller cell morphology', 0.5512820512820513, 8.040873045973026, 2.1054189575670126, 'HP:0000479', 'Abnormal retinal morphology'),
(461621, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102815', 'abnormal retinal ganglion cell morphology', 0.4777777777777778, 8.040873045973026, 1.960038381077836, 'HP:0000479', 'Abnormal retinal morphology'),
(461622, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129285', 'decreased size of the retinal inner plexiform layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461623, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0139912', 'abnormally necrotic optic fiber layer', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461624, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102212', 'abnormal globe morphology', 0.44285714285714284, 6.575878401988876, 1.7065095138559256, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461625, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140439', 'abnormally necrotic retinal stem cell', 0.48863636363636365, 8.040873045973026, 1.982186410418029, 'HP:0000479', 'Abnormal retinal morphology'),
(461626, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128875', 'decreased size of the photoreceptor layer', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461627, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130189', 'increased size of the optic chiasm', 0.44565217391304346, 7.796308075334707, 1.8639854190064706, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(461628, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128787', 'decreased size of the peripheral retina', 0.5308641975308642, 8.040873045973026, 2.066061861851679, 'HP:0000479', 'Abnormal retinal morphology'),
(461629, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0127563', 'abnormally localised retinal blood vessel', 0.5443037974683544, 8.040873045973026, 2.0920510830006163, 'HP:0000479', 'Abnormal retinal morphology'),
(461630, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130353', 'increased size of the photoreceptor layer', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461631, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0100329', 'abnormal retinal blood vessel', 0.6231884057971014, 8.040873045973026, 2.2385215779028833, 'HP:0000479', 'Abnormal retinal morphology'),
(461632, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128521', 'decreased size of the horizontal cell', 0.42574257425742573, 8.040873045973026, 1.850227550835222, 'HP:0000479', 'Abnormal retinal morphology'),
(461633, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130845', 'increased size of the retinal outer plexiform layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461634, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103048', 'abnormal cornea morphology', 0.4430379746835443, 6.887869297006056, 1.7468794071802813, 'HP:0012372', 'Abnormal eye morphology'),
(461635, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128710', 'decreased size of the optic chiasm', 0.44565217391304346, 7.796308075334707, 1.8639854190064706, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(461636, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141181', 'abnormally necrotic choroid', 0.4025974025974026, 6.575878401988876, 1.627092979653308, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461637, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130893', 'increased size of the pupil', 0.4069767441860465, 6.887869297006056, 1.6742767456052652, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461638, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0100779', 'abnormal optic choroid vascular plexus', 0.45588235294117646, 6.887869297006056, 1.7720208976957377, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461639, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128646', 'decreased size of the outer limiting membrane', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461640, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102946', 'abnormal retinal inner nuclear layer morphology', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461641, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140081', 'abnormally necrotic amacrine cell', 0.44329896907216493, 8.040873045973026, 1.8879911895239345, 'HP:0000479', 'Abnormal retinal morphology'),
(461642, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0133372', 'eye fused with olfactory epithelium', 0.47297297297297297, 6.887869297006056, 1.8049310288357878, 'HP:0012372', 'Abnormal eye morphology'),
(461643, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140192', 'abnormally necrotic retina', 0.5733333333333334, 8.040873045973026, 2.147114469784475, 'HP:0000479', 'Abnormal retinal morphology'),
(461644, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102882', 'abnormal retinal cone cell morphology', 0.48314606741573035, 8.040873045973026, 1.9710190741722953, 'HP:0000479', 'Abnormal retinal morphology'),
(461645, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102818', 'abnormal optic chiasm morphology', 0.4939759036144578, 7.796308075334707, 1.9624444772706708, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(461646, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140820', 'abnormally necrotic globe', 0.41333333333333333, 6.575878401988876, 1.6486448190828538, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461647, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102441', 'abnormal retinal inner plexiform layer morphology', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461648, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140487', 'abnormally necrotic retinal layer', 0.581081081081081, 8.040873045973026, 2.1615733164502497, 'HP:0000479', 'Abnormal retinal morphology'),
(461649, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129681', 'increased size of the eye photoreceptor cell', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(461650, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102162', 'abnormal ciliary marginal zone morphology', 0.5512820512820513, 8.040873045973026, 2.1054189575670126, 'HP:0000479', 'Abnormal retinal morphology'),
(461651, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129419', 'decreased size of the pupil', 0.40229885057471265, 6.887869297006056, 1.6646266551675757, 'HP:0012372', 'Abnormal eye morphology'),
(461652, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130859', 'increased size of the globe', 0.4025974025974026, 6.575878401988876, 1.627092979653308, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461653, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130326', 'increased size of the retinal cone cell', 0.4215686274509804, 8.040873045973026, 1.8411354685352277, 'HP:0000479', 'Abnormal retinal morphology'),
(461654, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129955', 'increased size of the retinal stem cell region', 0.5443037974683544, 8.040873045973026, 2.0920510830006163, 'HP:0000479', 'Abnormal retinal morphology'),
(461655, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129029', 'decreased size of the Muller cell', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461656, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102996', 'abnormal optic fiber layer morphology', 0.5119047619047619, 8.040873045973026, 2.028832472656439, 'HP:0000479', 'Abnormal retinal morphology'),
(461657, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140553', 'abnormally necrotic retinal stem cell region', 0.5584415584415584, 8.040873045973026, 2.1190464070010115, 'HP:0000479', 'Abnormal retinal morphology'),
(461658, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103086', 'abnormal amacrine cell morphology', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461659, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129038', 'decreased size of the retinal outer nuclear layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461660, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140464', 'abnormally necrotic retinal pigmented epithelium', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461661, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0128935', 'decreased size of the central retina', 0.5733333333333334, 8.040873045973026, 2.147114469784475, 'HP:0000479', 'Abnormal retinal morphology'),
(461662, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140531', 'abnormally necrotic retinal progenitor cell region', 0.5584415584415584, 8.040873045973026, 2.1190464070010115, 'HP:0000479', 'Abnormal retinal morphology'),
(461663, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102226', 'abnormal Jacobsons organ morphology', 0.42424242424242425, 5.788671267106304, 1.5670992092077785, 'UPHENO:0087472', 'abnormal face morphology'),
(461664, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129432', 'decreased size of the retinal stem cell', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(461665, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129388', 'decreased size of the sclera', 0.4430379746835443, 6.887869297006056, 1.7468794071802813, 'HP:0012372', 'Abnormal eye morphology'),
(461666, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102663', 'abnormal retinal progenitor cell morphology', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(461667, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102411', 'abnormal optic choroid vascular plexus morphology', 0.4111111111111111, 7.796308075334707, 1.7902929579863123, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(461668, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0101961', 'abnormal retinal blood vessel morphology', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(461669, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103155', 'abnormal bipolar neuron morphology', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461670, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103142', 'abnormal optic nerve morphology', 0.422680412371134, 7.796308075334707, 1.8153089853396518, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(461671, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140799', 'abnormally necrotic ciliary body', 0.4117647058823529, 6.887869297006056, 1.6840966347682629, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461672, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0141156', 'abnormally necrotic outer limiting membrane', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461673, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0101817', 'abnormal eye morphology', 0.49295774647887325, 6.887869297006056, 1.8426688597502066, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461674, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130079', 'increased size of the olfactory pit', 0.4057971014492754, 5.788671267106304, 1.532653261972336, 'UPHENO:0087472', 'abnormal face morphology'),
(461675, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129138', 'decreased size of the retinal progenitor cell', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(461676, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0102966', 'abnormal olfactory pit morphology', 0.4375, 5.788671267106304, 1.5913967699348293, 'UPHENO:0087472', 'abnormal face morphology'),
(461677, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0103926', 'decreased pigmentation in the retinal pigmented epithelium', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(461678, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0130515', 'increased size of the retinal outer nuclear layer', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(461679, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0127230', 'abnormally localised hyaloid blood vessel', 0.40789473684210525, 6.887869297006056, 1.6761639640277146, 'HP:0012372', 'Abnormal eye morphology'),
(461680, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0100371', 'abnormal hyaloid blood vessel', 0.4626865671641791, 6.887869297006056, 1.7851959556606887, 'HP:0012372', 'Abnormal eye morphology'),
(461681, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140006', 'abnormally necrotic retinal neural layer', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(461682, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0129062', 'decreased size of the ciliary body', 0.40229885057471265, 6.887869297006056, 1.6646266551675757, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461683, 'HP:0030505', 'Nummular pigmentation of the fundus', 'XPO:0140317', 'abnormally necrotic retinal progenitor cell', 0.48863636363636365, 8.040873045973026, 1.982186410418029, 'HP:0000479', 'Abnormal retinal morphology'),
(461684, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0103022', 'abnormal ciliary body morphology', 0.4155844155844156, 8.412768222102876, 1.869816933560547, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(461685, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0141141', 'abnormally necrotic cornea', 0.4935064935064935, 10.582693223545188, 2.2853069431931274, 'UPHENO:0020998', 'abnormal cornea morphology'),
(461686, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102259', 'abnormal pharyngeal region morphology', 0.4117647058823529, 4.5318002188002176, 1.3660290568695288, 'UPHENO:0087907', 'abnormal head morphology'),
(461687, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0103048', 'abnormal cornea morphology', 0.5352112676056338, 10.582693223545188, 2.3799110602825415, 'UPHENO:0020998', 'abnormal cornea morphology'),
(461688, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0141337', 'increased pigmentation in the eye', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461689, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0129260', 'decreased size of the cornea', 0.4578313253012048, 10.582693223545188, 2.201156165244023, 'UPHENO:0020998', 'abnormal cornea morphology'),
(461690, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0101315', 'abnormal hyaloid vascular plexus', 0.484375, 6.887869297006056, 1.8265573330003382, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461691, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102196', 'abnormal central retina morphology', 0.4025974025974026, 6.887869297006056, 1.6652442128423794, 'HP:0012372', 'Abnormal eye morphology'),
(461692, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0141323', 'edematous eye', 0.4305555555555556, 6.887869297006056, 1.7220947685207388, 'HP:0012372', 'Abnormal eye morphology'),
(461693, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102550', 'abnormal lens morphology', 0.4788732394366197, 9.014833150514745, 2.077730096467687, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461694, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0101817', 'abnormal eye morphology', 0.44285714285714284, 6.887869297006056, 1.7465228647932265, 'HP:0012372', 'Abnormal eye morphology'),
(461695, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0141638', 'neoplastic eye', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'HP:0012372', 'Abnormal eye morphology'),
(461696, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0128052', 'decreased size of the iris', 0.40476190476190477, 9.014833150514745, 1.910199213986099, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461697, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0133354', 'fused eyes', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461698, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0125589', 'absent hyaloid blood vessel', 0.4189189189189189, 6.887869297006056, 1.6986638159319787, 'HP:0012372', 'Abnormal eye morphology'),
(461699, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0127230', 'abnormally localised hyaloid blood vessel', 0.43661971830985913, 6.887869297006056, 1.734179792355427, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461700, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0127783', 'abnormally localised hyaloid vascular plexus', 0.40789473684210525, 6.887869297006056, 1.6761639640277146, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461701, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102831', 'abnormal optic disc morphology', 0.40298507462686567, 6.575878401988876, 1.6278761772821302, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(461702, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102476', 'abnormal lens transitional zone morphology', 0.4657534246575342, 9.014833150514745, 2.0490703776514145, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461703, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0139731', 'abnormally necrotic eye', 0.4025974025974026, 6.887869297006056, 1.6652442128423794, 'HP:0012372', 'Abnormal eye morphology'),
(461704, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0103210', 'abnormal pupil morphology', 0.44155844155844154, 9.014833150514745, 1.9951380094746995, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461705, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0128807', 'decreased size of the lens transitional zone', 0.425, 9.014833150514745, 1.957371729889028, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461706, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0101634', 'abnormal head morphology', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(461707, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0100371', 'abnormal hyaloid blood vessel', 0.5, 6.887869297006056, 1.8557841061133777, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461708, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0129419', 'decreased size of the pupil', 0.40963855421686746, 9.014833150514745, 1.9216719850908865, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461709, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0140473', 'abnormally necrotic lens transitional zone', 0.4358974358974359, 9.014833150514745, 1.982307406875276, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461710, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0130285', 'increased size of the lens transitional zone', 0.425, 9.014833150514745, 1.957371729889028, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461711, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0140218', 'abnormally necrotic sclera', 0.40789473684210525, 6.887869297006056, 1.6761639640277146, 'HP:0012372', 'Abnormal eye morphology'),
(461712, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0130893', 'increased size of the pupil', 0.4146341463414634, 9.014833150514745, 1.9333539892565992, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461713, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0128467', 'decreased size of the lens', 0.43037974683544306, 9.014833150514745, 1.969721200851099, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461714, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0101483', 'abnormal nostril', 0.41379310344827586, 5.788671267106304, 1.5476796336638217, 'UPHENO:0087472', 'abnormal face morphology'),
(461715, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102513', 'abnormal sclera morphology', 0.43661971830985913, 6.887869297006056, 1.734179792355427, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461716, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0133372', 'eye fused with olfactory epithelium', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461717, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0129532', 'increased size of the iris', 0.40476190476190477, 9.014833150514745, 1.910199213986099, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461718, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0127907', 'abnormally localised optic choroid vascular plexus', 0.4189189189189189, 6.887869297006056, 1.6986638159319787, 'HP:0012372', 'Abnormal eye morphology'),
(461719, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0100710', 'abnormal hyaloid vein', 0.484375, 6.887869297006056, 1.8265573330003382, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461720, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0103110', 'abnormal lens fiber cell mass morphology', 0.40963855421686746, 9.014833150514745, 1.9216719850908865, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461721, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102805', 'abnormal retinal layer morphology', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'HP:0012372', 'Abnormal eye morphology'),
(461722, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0100779', 'abnormal optic choroid vascular plexus', 0.49206349206349204, 6.887869297006056, 1.8409967461029664, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461723, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0100329', 'abnormal retinal blood vessel', 0.40789473684210525, 6.887869297006056, 1.6761639640277146, 'HP:0012372', 'Abnormal eye morphology'),
(461724, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0115417', 'abnormally wholly ventralized eye', 0.4025974025974026, 6.887869297006056, 1.6652442128423794, 'HP:0012372', 'Abnormal eye morphology'),
(461725, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0130736', 'increased size of the cornea', 0.4578313253012048, 10.582693223545188, 2.201156165244023, 'UPHENO:0020998', 'abnormal cornea morphology'),
(461726, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0101823', 'abnormal lens epithelium morphology', 0.425, 9.014833150514745, 1.957371729889028, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461727, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0129947', 'increased size of the lens', 0.43037974683544306, 9.014833150514745, 1.969721200851099, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461728, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0141343', 'decreased pigmentation in the eye', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461729, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0115423', 'abnormally incomplete structure of eye', 0.43661971830985913, 6.887869297006056, 1.734179792355427, 'HP:0012372', 'Abnormal eye morphology'),
(461730, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0133369', 'eye fused with brain', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'HP:0012372', 'Abnormal eye morphology'),
(461731, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0140375', 'abnormally necrotic lens', 0.4473684210526316, 9.014833150514745, 2.0082210218496126, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461732, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0140250', 'abnormally necrotic iris', 0.4146341463414634, 9.014833150514745, 1.9333539892565992, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461733, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102862', 'abnormal iris morphology', 0.44155844155844154, 9.014833150514745, 1.9951380094746995, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461734, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0133371', 'eye fused with olfactory pit', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'HP:0012372', 'Abnormal eye morphology'),
(461735, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102003', 'abnormal hyaloid blood vessel morphology', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'HP:0012372', 'Abnormal eye morphology'),
(461736, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0102117', 'abnormal retina morphology', 0.4025974025974026, 6.887869297006056, 1.6652442128423794, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461737, 'HP:0000627', 'Posterior embryotoxon', 'XPO:0127645', 'abnormally localised hyaloid vein', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'HP:0012372', 'Abnormal eye morphology'),
(461738, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0127645', 'abnormally localised hyaloid vein', 0.4025974025974026, 6.887869297006056, 1.6652442128423794, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461739, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0140375', 'abnormally necrotic lens', 0.4358974358974359, 9.014833150514745, 1.982307406875276, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461740, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0102550', 'abnormal lens morphology', 0.4657534246575342, 9.014833150514745, 2.0490703776514145, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461741, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0128467', 'decreased size of the lens', 0.41975308641975306, 9.014833150514745, 1.9452516645636548, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461742, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0133371', 'eye fused with olfactory pit', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461743, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0140250', 'abnormally necrotic iris', 0.40476190476190477, 9.014833150514745, 1.910199213986099, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461744, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0127907', 'abnormally localised optic choroid vascular plexus', 0.40789473684210525, 6.887869297006056, 1.6761639640277146, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461745, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0102805', 'abnormal retinal layer morphology', 0.4025974025974026, 6.887869297006056, 1.6652442128423794, 'HP:0012372', 'Abnormal eye morphology'),
(461746, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0129260', 'decreased size of the cornea', 0.4470588235294118, 10.582693223545188, 2.1751060623084086, 'UPHENO:0020998', 'abnormal cornea morphology'),
(461747, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0133369', 'eye fused with brain', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'HP:0012372', 'Abnormal eye morphology'),
(461748, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0102513', 'abnormal sclera morphology', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461749, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0103210', 'abnormal pupil morphology', 0.43037974683544306, 9.014833150514745, 1.969721200851099, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461750, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0140473', 'abnormally necrotic lens transitional zone', 0.425, 9.014833150514745, 1.957371729889028, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461751, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0133354', 'fused eyes', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'HP:0012372', 'Abnormal eye morphology'),
(461752, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0102476', 'abnormal lens transitional zone morphology', 0.4533333333333333, 9.014833150514745, 2.021564829919309, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461753, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0141337', 'increased pigmentation in the eye', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461754, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0141141', 'abnormally necrotic cornea', 0.4810126582278481, 10.582693223545188, 2.256193564095799, 'UPHENO:0020998', 'abnormal cornea morphology'),
(461755, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0101315', 'abnormal hyaloid vascular plexus', 0.4696969696969697, 6.887869297006056, 1.7986693238259617, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461756, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0128807', 'decreased size of the lens transitional zone', 0.4146341463414634, 9.014833150514745, 1.9333539892565992, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461757, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0100710', 'abnormal hyaloid vein', 0.4696969696969697, 6.887869297006056, 1.7986693238259617, 'HP:0012372', 'Abnormal eye morphology'),
(461758, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0130285', 'increased size of the lens transitional zone', 0.4146341463414634, 9.014833150514745, 1.9333539892565992, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461759, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0100779', 'abnormal optic choroid vascular plexus', 0.47692307692307695, 6.887869297006056, 1.8124524320853552, 'HP:0012372', 'Abnormal eye morphology'),
(461760, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0133372', 'eye fused with olfactory epithelium', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461761, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0129947', 'increased size of the lens', 0.41975308641975306, 9.014833150514745, 1.9452516645636548, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461762, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0127230', 'abnormally localised hyaloid blood vessel', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'HP:0012372', 'Abnormal eye morphology'),
(461763, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0130736', 'increased size of the cornea', 0.4470588235294118, 10.582693223545188, 2.1751060623084086, 'UPHENO:0020998', 'abnormal cornea morphology'),
(461764, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0115423', 'abnormally incomplete structure of eye', 0.4246575342465753, 6.887869297006056, 1.7102589253909142, 'HP:0012372', 'Abnormal eye morphology'),
(461765, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0101823', 'abnormal lens epithelium morphology', 0.4146341463414634, 9.014833150514745, 1.9333539892565992, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461766, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0125589', 'absent hyaloid blood vessel', 0.40789473684210525, 6.887869297006056, 1.6761639640277146, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461767, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0100371', 'abnormal hyaloid blood vessel', 0.484375, 6.887869297006056, 1.8265573330003382, 'HP:0012372', 'Abnormal eye morphology'),
(461768, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0141638', 'neoplastic eye', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461769, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0141343', 'decreased pigmentation in the eye', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'HP:0012372', 'Abnormal eye morphology'),
(461770, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0103022', 'abnormal ciliary body morphology', 0.4050632911392405, 8.412768222102876, 1.8459966369515974, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(461771, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0130893', 'increased size of the pupil', 0.40476190476190477, 9.014833150514745, 1.910199213986099, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461772, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0141323', 'edematous eye', 0.4189189189189189, 6.887869297006056, 1.6986638159319787, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461773, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0102862', 'abnormal iris morphology', 0.43037974683544306, 9.014833150514745, 1.969721200851099, 'UPHENO:0021038', 'abnormal anterior segment of eyeball morphology'),
(461774, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0103048', 'abnormal cornea morphology', 0.5205479452054794, 10.582693223545188, 2.347083128535587, 'UPHENO:0020998', 'abnormal cornea morphology'),
(461775, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0101817', 'abnormal eye morphology', 0.4305555555555556, 6.887869297006056, 1.7220947685207388, 'HP:0012372', 'Abnormal eye morphology'),
(461776, 'HP:0200066', 'Ribbonlike corneal degeneration', 'XPO:0102003', 'abnormal hyaloid blood vessel morphology', 0.4025974025974026, 6.887869297006056, 1.6652442128423794, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(461777, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0101850', 'abnormal epithelial cell morphology', 0.4090909090909091, 5.43643956286526, 1.491307481034791, 'HP:0025461', 'Abnormal cell morphology'),
(461778, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102423', 'abnormal multiciliated cell precursor morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461779, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102323', 'abnormal keratin accumulating cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461780, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102165', 'abnormal melanoblast morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461781, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0140973', 'abnormally necrotic erythroid cell', 0.40816326530612246, 5.574066539846944, 1.5083531416540121, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461782, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102434', 'abnormal exocrine cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461783, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102069', 'abnormal proepicardium morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461784, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0103080', 'abnormal myelin accumulating cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461785, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102958', 'abnormal cementoblast morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461786, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102860', 'abnormal mesenchymal stem cell morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461787, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0103167', 'abnormal absorptive cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461788, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102869', 'abnormal mucus secreting cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461789, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0101804', 'abnormal stem cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461790, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102336', 'abnormal Merkel cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461791, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102965', 'abnormal barrier epithelial cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461792, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102531', 'abnormal secondary spermatogonium morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461793, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102109', 'abnormal pericyte morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461794, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0140429', 'abnormally necrotic hemangioblast', 0.40816326530612246, 5.574066539846944, 1.5083531416540121, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461795, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102929', 'abnormal barrier cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461796, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102285', 'abnormal myoblast morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461797, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0101917', 'abnormal progenitor cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461798, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0101657', 'abnormal oocyte morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461799, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0103082', 'abnormal myeloid cell morphology', 0.4444444444444444, 5.574066539846944, 1.573964074113079, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461800, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0101940', 'abnormal early embryonic cell morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461801, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0103099', 'abnormal alkali secreting cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461802, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102534', 'abnormal spermatocyte morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461803, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102636', 'abnormal acid secreting cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461804, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102739', 'abnormal erythroid cell morphology', 0.4444444444444444, 5.574066539846944, 1.573964074113079, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(461805, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102258', 'abnormal primordial germ cell morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461806, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0139717', 'abnormally necrotic cell', 0.42857142857142855, 5.43643956286526, 1.526401870347189, 'HP:0025461', 'Abnormal cell morphology'),
(461807, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102386', 'abnormal electrically active cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461808, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0101921', 'abnormal chondroblast morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461809, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102181', 'abnormal mitotic cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461810, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102873', 'abnormal nucleate erythrocyte morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461811, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102347', 'abnormal ciliated cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461812, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102306', 'abnormal secondary oogonium morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461813, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0103005', 'abnormal oxygen accumulating cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461814, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0103067', 'abnormal paracrine cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461815, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0140331', 'abnormally necrotic myeloid cell', 0.40816326530612246, 5.574066539846944, 1.5083531416540121, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461816, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0101969', 'abnormal zygote morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461817, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102608', 'abnormal multiciliated cell morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461818, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0101658', 'abnormal germ cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461819, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0101636', 'abnormal cell morphology', 0.46153846153846156, 5.43643956286526, 1.5840220806831131, 'HP:0025461', 'Abnormal cell morphology'),
(461820, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102764', 'abnormal apoptotic cell morphology', 0.43902439024390244, 5.43643956286526, 1.5449043867452603, 'HP:0025461', 'Abnormal cell morphology'),
(461821, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102061', 'abnormal spermatid morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461822, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0107371', 'abnormal migrating myoblast morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461823, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102147', 'abnormal somatic stem cell morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461824, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0103219', 'abnormal hemangioblast morphology', 0.4444444444444444, 5.574066539846944, 1.573964074113079, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(461825, 'HP:0012528', 'Abnormal number of alpha granules', 'XPO:0102872', 'abnormal ciliated non-epidermal cell morphology', 0.4186046511627907, 5.43643956286526, 1.5085486027240909, 'HP:0025461', 'Abnormal cell morphology'),
(461826, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141748', 'abnormal gas homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461827, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100344', 'abnormal portion of organism substance', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461828, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141743', 'abnormal chemical homeostasis within a tissue', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461829, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100802', 'abnormal exocrine cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461830, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141783', 'abnormal collagen metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461831, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141907', 'abnormal putrescine metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461832, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100674', 'abnormal secondary oogonium', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461833, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101535', 'abnormal absorptive cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461834, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101468', 'abnormal stage I oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461835, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100724', 'abnormal kinetochore', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461836, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141771', 'abnormal urea homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461837, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131469', 'abnormal heart process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461838, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141796', 'abnormal demethylation', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461839, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461840, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100976', 'abnormal multiciliated cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461841, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141745', 'abnormal creatinine homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461842, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461843, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101061', 'abnormal plasma membrane', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461844, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141787', 'abnormal hormone metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461845, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461846, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100429', 'abnormal spermatid', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461847, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141770', 'abnormal urate homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461848, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461849, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100289', 'abnormal chondroblast', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461850, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141784', 'abnormal cellular hormone metabolic process', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461851, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100317', 'abnormal respiratory system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461852, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461853, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141790', 'abnormal cellular metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461854, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0107270', 'abnormal proximal-distal axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461855, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101435', 'abnormal paracrine cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461856, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100006', 'abnormal anatomical structure', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461857, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461858, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141852', 'abnormal glucose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461859, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141315', 'abnormal anatomical region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461860, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100549', 'abnormal mitotic cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461861, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100026', 'abnormal germ cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461862, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100721', 'abnormal centromere', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461863, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100437', 'abnormal proepicardium', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461864, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141267', 'abnormal resting posture', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461865, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100032', 'abnormal nervous system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461866, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100062', 'abnormal anatomical space', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461867, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101472', 'abnormal zygote cortex', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461868, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141903', 'abnormal inositol phosphate metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461869, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100917', 'abnormal stage III oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461870, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141884', 'abnormal phosphagen metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461871, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141850', 'abnormal galactose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461872, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141864', 'abnormal 5-methylcytosine metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461873, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100585', 'abnormal elastica externa', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461874, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141866', 'abnormal dicarboxylic acid metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461875, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100546', 'abnormal whole organism', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461876, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141797', 'abnormal hydrogen metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461877, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101264', 'abnormal mitotic spindle', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461878, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0107258', 'abnormal anatomical axis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461879, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131677', 'abnormal actin filament', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461880, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461881, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461882, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100108', 'abnormal cell part', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461883, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101513', 'abnormal basal body', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461884, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141881', 'abnormal fructose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461885, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101237', 'abnormal mucus secreting cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461886, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141264', 'abnormal schooling behavior', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461887, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461888, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100888', 'abnormal microtubule', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461889, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101461', 'abnormal sperm entry point', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461890, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141499', 'abnormal tadpole', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461891, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100638', 'abnormal polar body', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461892, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461893, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0107312', 'abnormal filopodium', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461894, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141794', 'abnormal prosthetic group metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461895, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141781', 'abnormal secondary metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461896, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100202', 'abnormal embryo', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461897, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100337', 'abnormal zygote', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461898, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0115505', 'dead whole organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461899, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141272', 'absent surface breathing', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461900, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141778', 'abnormal biosynthetic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461901, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461902, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131730', 'abnormal regulation of protein folding', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461903, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461904, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100308', 'abnormal early embryonic cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461905, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100477', 'abnormal pericyte', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461906, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141795', 'abnormal glycosylation', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461907, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101157', 'abnormal female organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461908, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141859', 'abnormal lactose catabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461909, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141908', 'abnormal pyridine metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461910, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100715', 'abnormal ciliated cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461911, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141263', 'abnormal visually guided collision avoidance behavior', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461912, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141883', 'abnormal glycerol metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461913, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100377', 'abnormal connective tissue', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461914, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0116434', 'abnormal biological process', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461915, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100004', 'abnormal cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(461916, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100025', 'abnormal oocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461917, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141792', 'abnormal small molecule metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461918, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100653', 'abnormal myoblast', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461919, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141898', 'abnormal maltose metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461920, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100574', 'abnormal gastrula cell', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461921, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461922, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100852', 'abnormal interdigital region', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461923, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100386', 'abnormal limb', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461924, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100307', 'abnormal blastomere', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461925, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0133388', 'absent insulin receptor signaling pathway', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461926, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141754', 'abnormal homeostatic process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461927, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101004', 'abnormal acid secreting cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461928, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101467', 'abnormal alkali secreting cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461929, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461930, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100599', 'abnormal adult immune system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461931, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100258', 'abnormal organ part', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461932, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100581', 'abnormal immune system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461933, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100728', 'abnormal cell condensation', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461934, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0107284', 'abnormal migrating myoblast', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461935, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100285', 'abnormal progenitor cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461936, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101409', 'abnormal perivitelline space', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461937, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141798', 'abnormal lipid metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461938, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141892', 'abnormal inositol metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461939, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141872', 'abnormal cholesterol metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461940, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100423', 'abnormal process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461941, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141860', 'abnormal malate-aspartate shuttle', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461942, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461943, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100956', 'abnormal centrosome', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461944, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141767', 'abnormal temperature homeostasis', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461945, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141854', 'abnormal glutathione metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461946, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101141', 'abnormal Keller explant', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461947, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0107261', 'abnormal dorsal-ventral axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461948, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100176', 'abnormal stage VI oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461949, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461950, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0107253', 'abnormal enteric nervous system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461951, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141772', 'abnormal water homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461952, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131694', 'abnormal RNA polymerase II activity', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461953, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:00000000', 'Xenopus phenotype', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461954, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461955, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0107260', 'abnormal anterior-posterior axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461956, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461957, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461958, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141789', 'abnormal hormone catabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461959, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0142057', 'abnormal desmosome', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461960, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100533', 'abnormal melanoblast', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461961, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141786', 'abnormal pigment metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461962, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141276', 'decreased surface breathing', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461963, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141788', 'abnormal hormone biosynthetic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461964, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100031', 'abnormal central nervous system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461965, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101109', 'abnormal egg cell-free extract', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461966, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141904', 'abnormal glucosamine metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461967, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100626', 'abnormal primordial germ cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461968, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100372', 'abnormal hematological system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461969, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461970, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141271', 'increased surface breathing', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461971, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0133403', 'abnormal developmental process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461972, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101480', 'abnormal stage V oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461973, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101132', 'abnormal apoptotic cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461974, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101297', 'abnormal barrier cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461975, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100545', 'abnormal male organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461976, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141777', 'abnormal catabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461977, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0107262', 'abnormal left-right axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461978, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100172', 'abnormal stem cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461979, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461980, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0128000', 'absent behavior', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461981, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100481', 'abnormal anatomical line', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461982, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141775', 'abnormal nitrogen compound metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461983, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0116494', 'absent biological process', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461984, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461985, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141266', 'abnormal surface breathing', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461986, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141265', 'abnormal escape behavior', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461987, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101326', 'abnormal cementoblast', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(461988, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141911', 'abnormal ribose phosphate metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461989, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131729', 'abnormal regulation of growth rate', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461990, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141776', 'abnormal metabolic process', 0.5789473684210527, 4.758907843651163, 1.6598666129060333, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(461991, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101498', 'abnormal stage II oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461992, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100232', 'abnormal lymphatic system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461993, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141600', 'absent metamorphosis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461994, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141809', 'abnormal catalytic activity', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(461995, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100907', 'abnormal cytoplasm', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461996, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101113', 'abnormal stage IV oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461997, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101366', 'abnormal morula cell', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(461998, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100225', 'abnormal endocrine system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(461999, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100392', 'abnormal cilium', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(462000, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141782', 'abnormal methylation', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(462001, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141880', 'abnormal ethanolamine metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(462002, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100902', 'abnormal spermatocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462003, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100501', 'abnormal urogenital system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462004, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101221', 'abnormal larval immune system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(462005, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100704', 'abnormal Merkel cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(462006, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100573', 'abnormal extraembryonic structure', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462007, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141791', 'abnormal primary metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(462008, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141900', 'abnormal mannose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(462009, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131675', 'abnormal spindle microtubule', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(462010, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131666', 'abnormal adherens junction', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462011, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100084', 'abnormal anatomical group', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462012, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101110', 'abnormal cell-free extract', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462013, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100754', 'abnormal electrically active cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(462014, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462015, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100274', 'abnormal sensory system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(462016, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101220', 'abnormal centriole', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(462017, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100515', 'abnormal somatic stem cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462018, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100894', 'abnormal nucleus', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462019, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131691', 'abnormal molecular function', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462020, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0131745', 'abnormal axis elongation', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(462021, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141910', 'abnormal D-ribose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(462022, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(462023, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(462024, 'HP:0410239', 'Positive urine norcotinine test', 'XPO:0141877', 'abnormal 2-deoxyribose 1-phosphate metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(462025, 'HP:0040045', 'Abnormal hemidiaphragm morphology', 'XPO:0100100', 'abnormal muscle', 0.4117647058823529, 5.968280811662945, 1.5676502776568768, 'UPHENO:0002816', 'abnormal musculature'),
(462026, 'HP:0040045', 'Abnormal hemidiaphragm morphology', 'XPO:0101732', 'abnormal muscle morphology', 0.4146341463414634, 6.895202660022325, 1.6908537691916898, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(462027, 'HP:0040045', 'Abnormal hemidiaphragm morphology', 'XPO:0100317', 'abnormal respiratory system', 0.43333333333333335, 6.780552239366747, 1.714129313594978, 'UPHENO:0004536', 'abnormal respiratory system'),
(462028, 'HP:0001971', 'Hypersplenism', 'XPO:0100922', 'abnormal lymph vessel', 0.43478260869565216, 8.696350005340756, 1.944484955316575, 'UPHENO:0075774', 'abnormal lymphatic part of lymphoid system'),
(462029, 'HP:0001971', 'Hypersplenism', 'XPO:0101013', 'abnormal ventral caudal lymphatic vessel', 0.425531914893617, 8.696350005340756, 1.923687726830363, 'UPHENO:0075774', 'abnormal lymphatic part of lymphoid system'),
(462030, 'HP:0001971', 'Hypersplenism', 'XPO:0126821', 'abnormally localised spleen', 0.4461538461538462, 10.484129389061598, 2.1627608861139516, 'HP:0001743', 'Abnormality of the spleen'),
(462031, 'HP:0001971', 'Hypersplenism', 'XPO:0141626', 'metaplastic spleen', 0.5471698113207547, 10.484129389061598, 2.395119850795616, 'HP:0001743', 'Abnormality of the spleen'),
(462032, 'HP:0001971', 'Hypersplenism', 'XPO:0100446', 'abnormal spleen', 0.5686274509803921, 10.484129389061598, 2.4416313747678444, 'HP:0001743', 'Abnormality of the spleen'),
(462033, 'HP:0001971', 'Hypersplenism', 'XPO:0100921', 'abnormal dorsal caudal lymphatic vessel', 0.425531914893617, 8.696350005340756, 1.923687726830363, 'UPHENO:0075774', 'abnormal lymphatic part of lymphoid system'),
(462034, 'HP:0001971', 'Hypersplenism', 'XPO:0102078', 'abnormal spleen morphology', 0.42028985507246375, 10.484129389061598, 2.099136303694845, 'HP:0001743', 'Abnormality of the spleen'),
(462035, 'HP:0001971', 'Hypersplenism', 'XPO:0141656', 'neoplastic spleen', 0.4084507042253521, 10.484129389061598, 2.069359812152522, 'HP:0001743', 'Abnormality of the spleen'),
(462036, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126705', 'abnormally localised larval alimentary system', 0.47619047619047616, 6.943507843324674, 1.8183597846259916, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462037, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127274', 'abnormally localised posterior hindgut endoderm', 0.4166666666666667, 6.943507843324674, 1.7009198299896289, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462038, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126425', 'abnormally localised posterior foregut', 0.46511627906976744, 6.943507843324674, 1.7970916870819136, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462039, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127614', 'abnormally localised dorsal posterior hindgut endoderm', 0.40816326530612246, 6.943507843324674, 1.683474037224831, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462040, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0115391', 'abnormally undifferentiated alimentary system', 0.40540540540540543, 5.05060299610679, 1.4309233924911664, 'HP:0025031', 'Abnormality of the digestive system'),
(462041, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0102155', 'abnormal midgut morphology', 0.41304347826086957, 5.725717590856133, 1.5378459966026063, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462042, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0139906', 'abnormally necrotic alimentary system', 0.40425531914893614, 5.725717590856133, 1.5213979729341773, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462043, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127393', 'abnormally localised pharyngeal cavity', 0.5, 6.943507843324674, 1.8632643187863436, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462044, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126499', 'abnormally localised liver and biliary system', 0.4878048780487805, 6.943507843324674, 1.8404013140464075, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462045, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0102125', 'abnormal liver and biliary system morphology', 0.4318181818181818, 5.725717590856133, 1.572408649075639, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462046, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126466', 'abnormally localised alimentary system', 0.5, 6.943507843324674, 1.8632643187863436, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462047, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0115392', 'abnormally incomplete structure of alimentary system', 0.4418604651162791, 5.725717590856133, 1.5905873876716587, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462048, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0102367', 'abnormal hindgut morphology', 0.41304347826086957, 5.725717590856133, 1.5378459966026063, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462049, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0107288', 'abnormal larval alimentary system', 0.40540540540540543, 5.05060299610679, 1.4309233924911664, 'HP:0025031', 'Abnormality of the digestive system'),
(462050, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126318', 'abnormally localised cell', 0.42105263157894735, 6.943507843324674, 1.7098486043568053, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462051, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127557', 'abnormally localised hepato-pancreatic duct', 0.43478260869565216, 6.943507843324674, 1.7375029362908783, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462052, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0142027', 'abnormally localised digestive tract', 0.47619047619047616, 6.943507843324674, 1.8183597846259916, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462053, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0142061', 'abnormal digestive tract morphology', 0.4318181818181818, 5.725717590856133, 1.572408649075639, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462054, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126967', 'abnormally localised peritoneum', 0.425531914893617, 6.943507843324674, 1.7189194828870833, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462055, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126608', 'abnormally localised foregut', 0.47619047619047616, 6.943507843324674, 1.8183597846259916, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462056, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127101', 'abnormally localised portion of organism substance', 0.42424242424242425, 6.943507843324674, 1.7163130833849478, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462057, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0131557', 'abnormally localised buccopharyngeal membrane', 0.4166666666666667, 6.943507843324674, 1.7009198299896289, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462058, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0102522', 'abnormal pharyngeal cavity morphology', 0.4523809523809524, 5.725717590856133, 1.6094115622847593, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462059, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126520', 'abnormally localised hindgut', 0.47619047619047616, 6.943507843324674, 1.8183597846259916, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462060, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126858', 'abnormally localised ventral pancreatic bud', 0.4166666666666667, 6.943507843324674, 1.7009198299896289, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462061, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126413', 'abnormally localised cell part', 0.41025641025641024, 6.943507843324674, 1.6877851173622813, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462062, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127173', 'abnormally localised anterior foregut', 0.46511627906976744, 6.943507843324674, 1.7970916870819136, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462063, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126551', 'abnormally localised hepato-pancreatic progenitor cell', 0.4166666666666667, 6.943507843324674, 1.7009198299896289, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462064, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0100152', 'abnormal alimentary system', 0.4166666666666667, 5.05060299610679, 1.45066119926208, 'HP:0025031', 'Abnormality of the digestive system'),
(462065, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0101788', 'abnormal foregut morphology', 0.41304347826086957, 5.725717590856133, 1.5378459966026063, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462066, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0115768', 'abnormally abaxially mislocalized anterior foregut', 0.45454545454545453, 6.943507843324674, 1.776552821838952, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462067, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0103013', 'abnormal ventral foregut morphology', 0.40425531914893614, 5.725717590856133, 1.5213979729341773, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462068, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0100493', 'abnormal liver and biliary system', 0.40540540540540543, 5.05060299610679, 1.4309233924911664, 'HP:0025031', 'Abnormality of the digestive system'),
(462069, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126321', 'abnormally localised anatomical structure', 0.42424242424242425, 6.943507843324674, 1.7163130833849478, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462070, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126624', 'abnormally localised anatomical line', 0.42424242424242425, 6.943507843324674, 1.7163130833849478, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462071, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126698', 'abnormally localised hindgut endoderm', 0.425531914893617, 6.943507843324674, 1.7189194828870833, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462072, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127495', 'abnormally localised proctodeum', 0.43478260869565216, 6.943507843324674, 1.7375029362908783, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462073, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126446', 'abnormally localised mouth primordium', 0.4166666666666667, 6.943507843324674, 1.7009198299896289, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462074, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0128341', 'decreased size of the pharyngeal cavity', 0.40425531914893614, 5.725717590856133, 1.5213979729341773, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462075, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127536', 'abnormally localised anterior hindgut endoderm', 0.4166666666666667, 6.943507843324674, 1.7009198299896289, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462076, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0141833', 'edematous alimentary system', 0.4318181818181818, 5.725717590856133, 1.572408649075639, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462077, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126575', 'abnormally localised pharyngeal arch', 0.40816326530612246, 6.943507843324674, 1.683474037224831, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462078, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0102653', 'abnormal dorsal foregut morphology', 0.40425531914893614, 5.725717590856133, 1.5213979729341773, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462079, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0103009', 'abnormal manicotto glandulare morphology', 0.4222222222222222, 5.725717590856133, 1.5548392859161184, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462080, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127721', 'abnormally localised manicotto glandulare', 0.46511627906976744, 6.943507843324674, 1.7970916870819136, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462081, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127881', 'abnormally localised digestive enzyme secreting cell', 0.4444444444444444, 6.943507843324674, 1.7567024466090089, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462082, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0101784', 'abnormal alimentary system morphology', 0.4523809523809524, 5.725717590856133, 1.6094115622847593, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462083, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126813', 'abnormally localised gall bladder primordium', 0.43478260869565216, 6.943507843324674, 1.7375029362908783, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462084, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127307', 'abnormally localised oral evagination', 0.47619047619047616, 6.943507843324674, 1.8183597846259916, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462085, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0107375', 'abnormal larval alimentary system morphology', 0.4318181818181818, 5.725717590856133, 1.572408649075639, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462086, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127678', 'abnormally localised ventral foregut', 0.46511627906976744, 6.943507843324674, 1.7970916870819136, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462087, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126550', 'abnormally localised first pancreatic bud', 0.43478260869565216, 6.943507843324674, 1.7375029362908783, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462088, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127867', 'abnormally localised ventral posterior hindgut endoderm', 0.40816326530612246, 6.943507843324674, 1.683474037224831, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462089, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0129821', 'increased size of the pharyngeal cavity', 0.40425531914893614, 5.725717590856133, 1.5213979729341773, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462090, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0102094', 'abnormal anterior foregut morphology', 0.40425531914893614, 5.725717590856133, 1.5213979729341773, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462091, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0102733', 'abnormal posterior foregut morphology', 0.40425531914893614, 5.725717590856133, 1.5213979729341773, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462092, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0102118', 'abnormal oral evagination morphology', 0.4222222222222222, 5.725717590856133, 1.5548392859161184, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462093, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126549', 'abnormally localised second pancreatic bud', 0.425531914893617, 6.943507843324674, 1.7189194828870833, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462094, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0102618', 'abnormal gut epithelium morphology', 0.40425531914893614, 5.725717590856133, 1.5213979729341773, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(462095, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0141697', 'abnormally localised tracheoesophageal fold', 0.4166666666666667, 6.943507843324674, 1.7009198299896289, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462096, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126972', 'abnormally localised gut epithelium', 0.43478260869565216, 6.943507843324674, 1.7375029362908783, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462097, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0126837', 'abnormally localised midgut', 0.47619047619047616, 6.943507843324674, 1.8183597846259916, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462098, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127838', 'abnormally localised dorsal foregut', 0.46511627906976744, 6.943507843324674, 1.7970916870819136, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462099, 'HP:0001545', 'Anteriorly placed anus', 'XPO:0127442', 'abnormally localised lung bud', 0.40816326530612246, 6.943507843324674, 1.683474037224831, 'UPHENO:0081755', 'abnormally localised anatomical entity in independent continuant'),
(462100, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100907', 'abnormal cytoplasm', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462101, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101498', 'abnormal stage II oocyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462102, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101162', 'abnormal stromal cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462103, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131675', 'abnormal spindle microtubule', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462104, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103037', 'abnormal ring structure morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462105, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131248', 'abnormally decreased number of acid secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462106, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100544', 'abnormal neuromast support cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462107, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100231', 'abnormal compound organ', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462108, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100817', 'abnormal intersomitic neuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462109, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100268', 'abnormal circulatory system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462110, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101658', 'abnormal germ cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462111, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100014', 'abnormal tissue', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462112, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131561', 'abnormally localised actin filament', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462113, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131096', 'abnormally increased number of exocrine cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462114, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100023', 'abnormal mesenchyme', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462115, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101518', 'abnormal B cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462116, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100377', 'abnormal connective tissue', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(462117, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101220', 'abnormal centriole', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462118, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131080', 'abnormally increased number of somatic stem cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462119, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125061', 'absent basal body', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462120, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107288', 'abnormal larval alimentary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462121, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100742', 'abnormal musculoskeletal system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462122, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100207', 'abnormal blastema', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462123, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127171', 'abnormally localised myelin accumulating cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462124, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141289', 'abnormal spindle microtubule morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462125, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131136', 'abnormally increased number of multiciliated cell precursor', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462126, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102306', 'abnormal secondary oogonium morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462127, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101501', 'abnormal parabrachial area', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(462128, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101136', 'abnormal ooplasm', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462129, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125694', 'absent migrating myoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462130, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102147', 'abnormal somatic stem cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462131, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0129551', 'increased size of the cell part', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462132, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107272', 'abnormal axial region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462133, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0130989', 'abnormally increased number of ciliated cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462134, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126387', 'abnormally localised stage V oocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462135, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102869', 'abnormal mucus secreting cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462136, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127363', 'abnormally localised barrier cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462137, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100521', 'abnormal animal blastomere', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462138, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101409', 'abnormal perivitelline space', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462139, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101074', 'abnormal germinal vesicle', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(462140, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100585', 'abnormal elastica externa', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(462141, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131559', 'abnormally localised spindle microtubule', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462142, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100427', 'abnormal olfactory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(462143, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100894', 'abnormal nucleus', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462144, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102434', 'abnormal exocrine cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462145, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126162', 'absent alkali secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462146, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103179', 'abnormal lampbrush chromosome morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462147, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100640', 'abnormal notochordal sheath', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462148, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462149, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131691', 'abnormal molecular function', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462150, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131145', 'abnormally increased number of polar body', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462151, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125693', 'absent mucus secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462152, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462153, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102872', 'abnormal ciliated non-epidermal cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462154, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102113', 'abnormal anatomical line morphology', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462155, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101096', 'abnormal tendon', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462156, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100520', 'abnormal blastomere D1.2', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462157, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131129', 'abnormally increased number of chondroblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462158, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126154', 'absent ciliated non-epidermal cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462159, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0133443', 'abnormally increased number of cilium in the multiciliated cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462160, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101221', 'abnormal larval immune system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(462161, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125160', 'absent exocrine cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462162, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125559', 'absent electrically active cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462163, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125454', 'absent myoblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462164, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107371', 'abnormal migrating myoblast morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462165, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101092', 'abnormal dorso-lateral marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462166, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125716', 'absent multiciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462167, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462168, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127896', 'abnormally localised ring structure', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462169, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100842', 'abnormal left-dorsal blastomere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462170, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103099', 'abnormal alkali secreting cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462171, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0124884', 'absent keratin accumulating cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462172, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100872', 'abnormal neuroendocrine cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462173, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100152', 'abnormal alimentary system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(462174, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0115391', 'abnormally undifferentiated alimentary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462175, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127018', 'abnormally localised ciliated cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462176, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127653', 'abnormally localised Merkel cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462177, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100667', 'abnormal vegetal yolk mass', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462178, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101083', 'abnormal T cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462179, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100642', 'abnormal gustatory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(462180, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131205', 'abnormally decreased number of ciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462181, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0116091', 'abnormally increased variability of size of cell in endoderm', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462182, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131220', 'abnormally decreased number of proepicardium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462183, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100335', 'abnormal commissural interneuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462184, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100551', 'abnormal oocyte cortex', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462185, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100882', 'abnormal perichondrial cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462186, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126145', 'absent spermatid', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462187, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100481', 'abnormal anatomical line', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462188, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101468', 'abnormal stage I oocyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462189, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127683', 'abnormally localised centromere', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462190, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101078', 'abnormal mucous gland', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462191, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101515', 'abnormal neuromast mantle cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462192, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125013', 'absent early embryonic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462193, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100218', 'abnormal epithelial cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462194, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100192', 'abnormal epithelium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462195, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100070', 'abnormal anatomical system', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462196, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127743', 'abnormally localised perivitelline space', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462197, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131669', 'abnormal Roux spot', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462198, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141272', 'absent surface breathing', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462199, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107266', 'abnormal dorsal side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462200, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100249', 'abnormal avascular GAG-rich matrix', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462201, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141288', 'abnormal astral microtubule morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462202, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103642', 'increased cell population proliferation', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462203, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462204, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0142066', 'abnormally increased number of desmosome', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462205, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100623', 'abnormal olfactory sensory neuron', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462206, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101466', 'abnormal secondary myofiber', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462207, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462208, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131666', 'abnormal adherens junction', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462209, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101326', 'abnormal cementoblast', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462210, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103145', 'abnormal basal body morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462211, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100415', 'abnormal secretory epithelial cell', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(462212, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131515', 'absent Roux spot', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462213, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0142065', 'abnormally decreased number of desmosome', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462214, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100733', 'abnormal fibroblast', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462215, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127513', 'abnormally localised nucleate erythrocyte', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462216, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100422', 'abnormal notochord', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(462217, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102965', 'abnormal barrier epithelial cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462218, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0133445', 'abnormally increased number of cilium in the ciliated non-epidermal cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462219, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100337', 'abnormal zygote', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462220, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131061', 'abnormally increased number of keratin accumulating cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462221, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100800', 'abnormal ventral marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462222, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462223, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100596', 'abnormal myocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462224, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126472', 'abnormally localised secondary spermatogonium', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462225, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103631', 'abnormally increased number of apoptotic cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462226, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125115', 'absent paracrine cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462227, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100273', 'abnormal visual system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(462228, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141748', 'abnormal gas homeostasis', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462229, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141299', 'abnormal actin filament morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462230, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101463', 'abnormal right-ventral blastomere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462231, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103093', 'abnormal sperm entry point morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462232, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100913', 'abnormal Brachets cleft', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462233, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101435', 'abnormal paracrine cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462234, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101587', 'abnormal hemangioblast', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462235, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141777', 'abnormal catabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462236, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0116494', 'absent biological process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462237, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125879', 'absent spermatocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462238, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100816', 'abnormal blastocoel anlage', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462239, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125976', 'absent centriole', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462240, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102693', 'abnormal plasma membrane morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462241, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100402', 'abnormal zeugopod', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462242, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0142052', 'abnormal nasal region', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462243, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141285', 'abnormal cortical actin cytoskeleton morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462244, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100638', 'abnormal polar body', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462245, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131032', 'abnormally increased number of acid secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462246, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107263', 'abnormal anatomical side', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462247, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101107', 'abnormal erythroid cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462248, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100468', 'abnormal muscular system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462249, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141314', 'abnormal Roux spot morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462250, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100344', 'abnormal portion of organism substance', 0.5294117647058824, 1.706362323152461, 0.9504568842024205, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462251, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131383', 'abnormally decreased number of cementoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462252, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0130988', 'abnormally increased number of pericyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462253, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101543', 'abnormal external gill', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(462254, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126725', 'abnormally localised epithelial cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462255, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100991', 'abnormal iliac process primordium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462256, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100395', 'abnormal blastomere D1.1', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462257, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102704', 'abnormal mitochondrial cloud morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462258, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102929', 'abnormal barrier cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462259, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0115758', 'abnormally decreased mobility of melanoblast', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(462260, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100868', 'abnormal transporting epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462261, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125114', 'absent mesenchymal stem cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462262, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100728', 'abnormal cell condensation', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462263, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125997', 'absent Merkel cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462264, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101350', 'abnormal blastomere D2.1.2', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462265, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127533', 'abnormally localised spermatocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462266, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100587', 'abnormal vestibuloauditory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(462267, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0128071', 'decreased size of the cell part', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462268, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141776', 'abnormal metabolic process', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(462269, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102534', 'abnormal spermatocyte morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462270, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100665', 'abnormal egg jelly', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462271, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107273', 'abnormal basal region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462272, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100702', 'abnormal glial cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462273, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0133471', 'abnormally decreased number of cilium in the ciliated cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462274, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100034', 'abnormal blastomere V1.1', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462275, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100296', 'abnormal tail region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462276, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131513', 'absent actin cytoskeleton', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462277, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127399', 'abnormally localised melanoblast', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462278, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141783', 'abnormal collagen metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462279, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127435', 'abnormally localised mitotic spindle', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462280, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131300', 'abnormally decreased number of alkali secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462281, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125785', 'absent mitotic spindle', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462282, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131007', 'abnormally increased number of spermatid', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462283, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131314', 'abnormally decreased number of exocrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462284, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131247', 'abnormally decreased number of nucleate erythrocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462285, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100967', 'abnormal blastomere V2.1.2', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462286, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127902', 'abnormally localised stage II oocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462287, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100084', 'abnormal anatomical group', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462288, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126738', 'abnormally localised paracrine cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462289, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0133441', 'abnormally increased number of cilium in the ciliated cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462290, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102764', 'abnormal apoptotic cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462291, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131551', 'abnormally localised actin cytoskeleton', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462292, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103067', 'abnormal paracrine cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462293, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100031', 'abnormal central nervous system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(462294, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131068', 'abnormally increased number of migrating myoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462295, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101113', 'abnormal stage IV oocyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462296, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126548', 'abnormally localised centrosome', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462297, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126318', 'abnormally localised cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462298, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131066', 'abnormally increased number of myoblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462299, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100814', 'abnormal natural killer cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462300, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100861', 'abnormal blastomere D2.2.2', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462301, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462302, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131165', 'abnormally increased number of cementoblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462303, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131354', 'abnormally decreased number of multiciliated cell precursor', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462304, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107268', 'abnormal left side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462305, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0142030', 'abnormally localised desmosome', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462306, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101940', 'abnormal early embryonic cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462307, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100002', 'abnormal head', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462308, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100701', 'abnormal microglial cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462309, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100398', 'abnormal vegetal blastomere', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462310, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103104', 'abnormal zygote cortex morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462311, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101513', 'abnormal basal body', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462312, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131090', 'abnormally increased number of oxygen accumulating cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462313, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101212', 'abnormal glomeral mesenchyme', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462314, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100854', 'abnormal spiracle', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462315, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100786', 'abnormal presumptive axial mesoderm', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462316, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462317, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141784', 'abnormal cellular hormone metabolic process', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462318, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103005', 'abnormal oxygen accumulating cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462319, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101451', 'abnormal dorsal lymph space', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(462320, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100627', 'abnormal pharyngeal region', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(462321, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0142051', 'abnormal cerebrospinal fluid', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462322, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131550', 'abnormally localised adherens junction', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462323, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101109', 'abnormal egg cell-free extract', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462324, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141267', 'abnormal resting posture', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462325, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126232', 'absent ring structure', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462326, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101349', 'abnormal trunk region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462327, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100203', 'abnormal endocrine cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462328, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126630', 'abnormally localised early embryonic cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462329, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100796', 'abnormal pseudoblastema', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462330, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141787', 'abnormal hormone metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462331, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141315', 'abnormal anatomical region', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462332, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131180', 'abnormally decreased number of cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462333, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462334, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101347', 'abnormal hindlimb region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462335, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107426', 'abnormal yolk platelet morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462336, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101461', 'abnormal sperm entry point', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462337, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141775', 'abnormal nitrogen compound metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462338, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101327', 'abnormal blastomere V1.2.1', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462339, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100954', 'abnormal neural progenitor cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462340, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100965', 'abnormal blastomere V2.2', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462341, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125824', 'absent nucleus', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462342, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131202', 'abnormally decreased number of germ cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462343, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0133473', 'abnormally decreased number of cilium in the ciliated non-epidermal cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462344, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100654', 'abnormal blastomere V2.1', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462345, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131110', 'abnormally increased number of paracrine cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462346, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126133', 'absent mitotic cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462347, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100394', 'abnormal marginal zone', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462348, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101224', 'abnormal dorsal involuting marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462349, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:00000000', 'Xenopus phenotype', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462350, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100493', 'abnormal liver and biliary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462351, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101969', 'abnormal zygote morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462352, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102165', 'abnormal melanoblast morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462353, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102061', 'abnormal spermatid morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462354, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100674', 'abnormal secondary oogonium', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462355, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141841', 'abnormality of whole organism mass', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462356, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100062', 'abnormal anatomical space', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462357, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462358, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100581', 'abnormal immune system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(462359, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100610', 'abnormal appendage', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462360, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126388', 'abnormally localised oocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462361, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100704', 'abnormal Merkel cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462362, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127372', 'abnormally localised polar body', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462363, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0130968', 'abnormally increased number of early embryonic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462364, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127824', 'abnormally localised alkali secreting cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462365, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102423', 'abnormal multiciliated cell precursor morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462366, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101004', 'abnormal acid secreting cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462367, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0133436', 'abnormal cilium morphology in the multiciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462368, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100509', 'abnormal germ plasm', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462369, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131347', 'abnormally decreased number of myelin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462370, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101917', 'abnormal progenitor cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462371, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101010', 'abnormal dorsal marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462372, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127257', 'abnormally localised wedge region', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462373, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131706', 'abnormal ciliary basal body organization', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462374, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100172', 'abnormal stem cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462375, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101166', 'abnormal premigratory neural crest cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462376, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131371', 'abnormally decreased number of electrically active cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462377, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101485', 'abnormal descending interneuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462378, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127338', 'abnormally localised mucus secreting cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462379, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100976', 'abnormal multiciliated cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462380, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102539', 'abnormal cytoplasm morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462381, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127168', 'abnormally localised chondroblast', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462382, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100256', 'abnormal paired appendage', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462383, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462384, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141778', 'abnormal biosynthetic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462385, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100713', 'abnormal monociliated cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462386, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100164', 'abnormal neural nucleus', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462387, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0124845', 'absent stem cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462388, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102109', 'abnormal pericyte morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462389, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126413', 'abnormally localised cell part', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462390, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100201', 'abnormal cavitated compound organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462391, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101573', 'abnormal peripheral vegetal yolk mass', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462392, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100009', 'abnormal multi-tissue structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462393, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103167', 'abnormal absorptive cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462394, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100108', 'abnormal cell part', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462395, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101079', 'abnormal blastomere D1.1.2', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462396, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100531', 'abnormal proliferative region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462397, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0124984', 'absent progenitor cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462398, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131075', 'abnormally increased number of mucus secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462399, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103080', 'abnormal myelin accumulating cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462400, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125724', 'absent polar body', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462401, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107311', 'abnormal apical junction complex', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462402, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102934', 'abnormal subcortical cytoplasm morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462403, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103129', 'abnormal ciliary axoneme morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462404, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141791', 'abnormal primary metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462405, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0124864', 'absent germ cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462406, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101094', 'abnormal blastomere V2.2.1', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462407, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100612', 'abnormal unilaminar epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462408, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102873', 'abnormal nucleate erythrocyte morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462409, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462410, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100827', 'abnormal atypical epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462411, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0116434', 'abnormal biological process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462412, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101283', 'abnormal left-ventral blastomere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462413, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100569', 'abnormal motor axon', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462414, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131655', 'abnormal myofibril', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462415, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100807', 'abnormal matrix-based tissue', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462416, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141497', 'abnormal lymphoblast', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462417, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127428', 'abnormally localised endoplasmic reticulum', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462418, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101040', 'abnormal axial mesoderm', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462419, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100676', 'abnormal blastomere D2.2', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462420, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100285', 'abnormal progenitor cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462421, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100839', 'abnormal skeletal myocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462422, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126158', 'absent ciliary axoneme', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462423, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0142057', 'abnormal desmosome', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462424, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0130986', 'abnormally increased number of germ cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462425, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100912', 'abnormal trabecula', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462426, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127520', 'abnormally localised gastrula cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462427, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141771', 'abnormal urea homeostasis', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462428, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127160', 'abnormally localised acid secreting cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462429, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100316', 'abnormal gamete', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462430, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0124782', 'absent oocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462431, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100458', 'abnormal autopod', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462432, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462433, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101322', 'abnormal iridophore', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462434, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131687', 'abnormal astral microtubule', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462435, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100916', 'abnormal principal cavity', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(462436, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103265', 'absent spindle microtubule', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462437, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102860', 'abnormal mesenchymal stem cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462438, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100557', 'abnormal prime meridian', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462439, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141792', 'abnormal small molecule metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462440, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101514', 'abnormal dendrite', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462441, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0130979', 'abnormally increased number of Merkel cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462442, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100754', 'abnormal electrically active cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462443, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0142056', 'abnormal main body axis', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462444, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107284', 'abnormal migrating myoblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462445, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100675', 'abnormal dorsal vegetal hemisphere blastomere', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462446, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100372', 'abnormal hematological system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(462447, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126982', 'abnormally localised secondary oogonium', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462448, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462449, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101657', 'abnormal oocyte morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462450, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127364', 'abnormally localised multiciliated cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462451, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0124863', 'absent secondary spermatogonium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462452, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100120', 'abnormal genital system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462453, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101029', 'abnormal right spleen primordium', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(462454, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100802', 'abnormal exocrine cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462455, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100397', 'abnormal ventral vegetal hemisphere blastomere', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462456, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131363', 'abnormally decreased number of polar body', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462457, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100265', 'abnormal sensory epithelial cell', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(462458, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131346', 'abnormally decreased number of chondroblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462459, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101472', 'abnormal zygote cortex', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462460, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101467', 'abnormal alkali secreting cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462461, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101575', 'abnormal vitelline membrane', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462462, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126159', 'absent apoptotic cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462463, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125384', 'absent ciliated cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462464, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102386', 'abnormal electrically active cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462465, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100188', 'abnormal delta cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462466, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0124807', 'absent cell part', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462467, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100225', 'abnormal endocrine system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(462468, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101576', 'abnormal blastomere V1.2.2', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462469, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101198', 'abnormal digestive enzyme secreting cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462470, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127643', 'abnormally localised somatic stem cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462471, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101072', 'abnormal mitochondrial cloud', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462472, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102531', 'abnormal secondary spermatogonium morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462473, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125053', 'absent zygote', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462474, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127089', 'abnormally localised myoblast', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462475, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141797', 'abnormal hydrogen metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462476, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141904', 'abnormal glucosamine metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462477, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131292', 'abnormally decreased number of mucus secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462478, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131108', 'abnormally increased number of ciliated non-epidermal cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462479, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101450', 'abnormal myeloid cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462480, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100378', 'abnormal perichondrium', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(462481, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102336', 'abnormal Merkel cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462482, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125779', 'absent endoplasmic reticulum', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462483, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141782', 'abnormal methylation', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462484, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100484', 'abnormal cement gland primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462485, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125394', 'absent multiciliated cell precursor', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462486, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125523', 'absent acid secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462487, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127029', 'abnormally localised multiciliated cell precursor', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462488, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100863', 'abnormal spinal neuron', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462489, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0142054', 'abnormal digestive tract', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(462490, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101638', 'abnormal anatomical structure morphology', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462491, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101976', 'abnormal portion of organism substance morphology', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462492, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100888', 'abnormal microtubule', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462493, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131708', 'abnormal cilium disassembly', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462494, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100537', 'abnormal medium cavity', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(462495, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107339', 'abnormal yolk platelet', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462496, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100025', 'abnormal oocyte', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462497, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131677', 'abnormal actin filament', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462498, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100546', 'abnormal whole organism', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462499, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125530', 'absent chondroblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462500, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107262', 'abnormal left-right axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462501, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100067', 'abnormal animal hemisphere', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462502, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100724', 'abnormal kinetochore', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462503, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107271', 'abnormal apical region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462504, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101297', 'abnormal barrier cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462505, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0130964', 'abnormally increased number of cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462506, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462507, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100533', 'abnormal melanoblast', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462508, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103644', 'abnormally decreased number of cilium in the multiciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462509, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101061', 'abnormal plasma membrane', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462510, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100251', 'abnormal proteinaceous extracellular matrix', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462511, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101740', 'abnormal cell part morphology', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462512, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131531', 'absent cortical actin cytoskeleton', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462513, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100332', 'abnormal germinal granule', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462514, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462515, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100232', 'abnormal lymphatic system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(462516, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101237', 'abnormal mucus secreting cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462517, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107258', 'abnormal anatomical axis', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462518, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125577', 'absent cilium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462519, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102526', 'abnormal nucleus morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462520, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125859', 'absent nucleate erythrocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462521, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100196', 'abnormal neuron', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462522, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100784', 'abnormal left blastomere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462523, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141796', 'abnormal demethylation', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462524, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126473', 'abnormally localised germ cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462525, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126671', 'abnormally localised zygote', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462526, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107325', 'abnormal adult thrombocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462527, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101490', 'abnormal ectodermal cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462528, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101519', 'abnormal hypobranchial placode', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462529, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100553', 'abnormal laryngeal muscle primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462530, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100917', 'abnormal stage III oocyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(462531, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0142023', 'absent desmosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462532, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100547', 'abnormal blastomere V2', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462533, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101577', 'abnormal notochordal epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462534, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101325', 'abnormal blastomere D2.1.1', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462535, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107270', 'abnormal proximal-distal axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462536, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462537, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102588', 'abnormal centrosome morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462538, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126983', 'abnormally localised primordial germ cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462539, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127876', 'abnormally localised microtubule', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462540, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100336', 'abnormal interneuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462541, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125692', 'absent oxygen accumulating cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462542, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131131', 'abnormally increased number of absorptive cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462543, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100293', 'abnormal duct', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462544, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126681', 'abnormally localised basal body', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462545, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141511', 'abnormally localised nucleus in myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462546, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127607', 'abnormally localised stage IV oocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462547, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101016', 'abnormal egg', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462548, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100003', 'abnormal organism subdivision', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462549, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103894', 'abnormally decreased number of spindle microtubule', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462550, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100573', 'abnormal extraembryonic structure', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462551, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103207', 'abnormal vitelline membrane morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462552, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101553', 'abnormal dental epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462553, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127343', 'abnormally localised filopodium', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462554, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102608', 'abnormal multiciliated cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462555, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100843', 'abnormal fasciculated network of fibrils', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462556, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102636', 'abnormal acid secreting cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462557, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100151', 'abnormal primordium', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462558, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100501', 'abnormal urogenital system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(462559, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131031', 'abnormally increased number of nucleate erythrocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462560, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100887', 'abnormal right-dorsal blastomere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462561, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141265', 'abnormal escape behavior', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(462562, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127339', 'abnormally localised migrating myoblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462563, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100989', 'abnormal right blastomere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462564, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141296', 'abnormal adherens junction morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462565, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107324', 'abnormal embryonic thrombocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462566, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126737', 'abnormally localised mesenchymal stem cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462567, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100162', 'abnormal presumptive rhombomere', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462568, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101037', 'abnormal hatching gland cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462569, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107399', 'abnormal filopodium morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462570, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100715', 'abnormal ciliated cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462571, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100416', 'abnormal ligament', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462572, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127815', 'abnormally localised ciliated non-epidermal cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462573, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131553', 'abnormally localised Roux spot', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462574, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141498', 'abnormal axon microtubule bundle', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462575, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141499', 'abnormal tadpole', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462576, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100643', 'abnormal thoracic region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462577, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100363', 'abnormal cardiovascular system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462578, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101149', 'abnormal amputated limb', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462579, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0102285', 'abnormal myoblast morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462580, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131053', 'abnormally increased number of primordial germ cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462581, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100449', 'abnormal lymphocyte', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(462582, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101009', 'abnormal blastomere D1.1.1', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462583, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0115505', 'dead whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462584, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462585, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141786', 'abnormal pigment metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(462586, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127734', 'abnormally localised stage III oocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462587, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100277', 'abnormal blastocoel', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462588, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107253', 'abnormal enteric nervous system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(462589, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100258', 'abnormal organ part', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462590, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125988', 'absent somatic stem cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462591, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101504', 'abnormal blastomere D2.2.1', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462592, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0103021', 'abnormal wedge region morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462593, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101850', 'abnormal epithelial cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462594, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101570', 'abnormal forelimb region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462595, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100862', 'abnormal blastomere V1', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462596, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100202', 'abnormal embryo', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462597, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100864', 'abnormal dorsolateral ascending neuron', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462598, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100762', 'abnormal intersomitic region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462599, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141714', 'abnormal anterior notochord', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462600, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107265', 'abnormal posterior side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462601, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107303', 'abnormal migratory trunk neural crest cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462602, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101158', 'abnormal blastomere V2.2.2', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462603, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100026', 'abnormal germ cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462604, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100545', 'abnormal male organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462605, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100035', 'abnormal ventral animal hemisphere blastomere', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462606, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100205', 'abnormal limb segment', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(462607, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101023', 'abnormal ultimobranchial body', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462608, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127508', 'abnormally localised barrier epithelial cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462609, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125076', 'absent proepicardium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462610, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131654', 'abnormal neuron projection', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462611, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127740', 'abnormally localised yolk platelet', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462612, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131184', 'abnormally decreased number of early embryonic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462613, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125868', 'absent cementoblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462614, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101374', 'abnormal migratory neural crest cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462615, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101424', 'abnormal coelomic epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462616, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100644', 'abnormal smooth muscle myocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462617, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101503', 'abnormal organ cortex', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462618, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100189', 'abnormal enteroendocrine cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(462619, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127806', 'abnormally localised spermatid', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462620, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131089', 'abnormally increased number of mitotic cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462621, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101110', 'abnormal cell-free extract', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462622, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100032', 'abnormal nervous system', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(462623, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107286', 'abnormal efferent neuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(462624, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100924', 'abnormal spermatozoon', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462625, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100511', 'abnormal stylopod', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(462626, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131004', 'abnormally increased number of proepicardium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462627, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126454', 'abnormally localised stem cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(462628, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131348', 'abnormally decreased number of absorptive cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462629, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101804', 'abnormal stem cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462630, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131283', 'abnormally decreased number of myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462631, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100956', 'abnormal centrosome', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462632, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101176', 'abnormal non-ciliated epithelial cell', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(462633, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0141860', 'abnormal malate-aspartate shuttle', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(462634, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131130', 'abnormally increased number of myelin accumulating cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462635, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0125743', 'absent lampbrush chromosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462636, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127752', 'abnormally localised stage VI oocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462637, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0126214', 'absent microtubule', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(462638, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100289', 'abnormal chondroblast', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(462639, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101921', 'abnormal chondroblast morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462640, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0131195', 'abnormally decreased number of Merkel cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462641, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100216', 'abnormal hepato-pancreatic progenitor cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(462642, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127391', 'abnormally localised lampbrush chromosome', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(462643, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101497', 'abnormal ciliary axoneme', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(462644, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0107264', 'abnormal anterior side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(462645, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0101264', 'abnormal mitotic spindle', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(462646, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0127641', 'abnormally localised vitelline membrane', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(462647, 'HP:0031551', 'Reduced cell surface marker level', 'XPO:0100745', 'abnormal anterior lymph sac', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
